The most comprehensive
neurotech company database

BrainPatch develops AI-powered brain-computer interface technology designed to restore communication and motor function for individuals with neurological conditions. The company's platform leverages machine learning algorithms to decode neural signals and translate them into actionable commands for external devices.

HABS (Human Augmented Brain System) develops neurotechnology solutions designed to enhance cognitive function and brain performance through advanced neural interfaces and AI integration. The company focuses on creating tools that augment human mental capabilities for improved productivity and cognitive outcomes.

Lacework provides cloud security and compliance automation through AI-driven analysis of cloud infrastructure, data, and user behavior across major cloud platforms. The platform enables organizations to detect and respond to threats, manage vulnerabilities, and maintain regulatory compliance at scale.

Neuralace Medical® develops innovative neurotechnology solutions for clinical applications, focusing on advanced medical devices and treatments for neurological conditions. The company specializes in designing minimally invasive technologies that enhance patient outcomes in neurology and neurosurgery.

NeuroStim TMS Centers provides transcranial magnetic stimulation (TMS) therapy for patients with treatment-resistant depression and other neurological conditions. The centers offer FDA-cleared TMS protocols administered by trained medical professionals in a clinical setting.

Advanced NeuroFeedback & NeuroSkilling GmbH provides neurofeedback training and neuro-optimization services designed to enhance cognitive performance and mental well-being. The company specializes in evidence-based neurotechnology applications for individuals and organizations seeking to improve focus, emotional regulation, and overall neurological function.

Alpha-Stim, by Electromedical Products International, manufactures FDA-cleared microcurrent medical devices designed to treat anxiety, depression, insomnia, and acute and chronic pain. The company's flagship Alpha-Stim systems deliver cranial electrotherapy stimulation (CES) and microcurrent electrical therapy (MET) for both clinical and home use.

ATLAS Neuroengineering develops neuroengineering solutions and technologies for neuroscience research and clinical applications. The company specializes in brain-computer interfaces and neural signal processing systems designed to advance neurotechnology development.

Baldoni Neuromodulation develops and manufactures neuromodulation devices and systems designed to treat neurological and pain-related conditions. The company specializes in innovative therapeutic solutions that utilize electrical stimulation and related neuromodulation technologies.

Brain Products GmbH develops advanced EEG amplifiers, software, and systems for neuroscience research and clinical applications. The company provides integrated solutions for brain activity monitoring across academic, pharmaceutical, and medical institutions worldwide.

BRAINLI Neurofeedback develops and provides neurofeedback solutions that enable real-time monitoring and self-regulation of brain activity through visual and auditory feedback mechanisms. The company specializes in applications for cognitive enhancement, stress reduction, and neurological wellness across clinical and consumer markets.

Brainscores provides AI-powered cognitive assessment and brain training solutions designed to measure and enhance mental performance. The platform leverages neuroscience-based algorithms to deliver personalized cognitive evaluations and training programs.

California Neurofeedback provides neurofeedback therapy services utilizing real-time brain activity monitoring to help clients optimize cognitive and emotional functioning. The company specializes in EEG-based neurofeedback training designed to address conditions such as ADHD, anxiety, and sleep disorders.

ClearPoint Neuro develops minimally invasive neurosurgical platforms and software solutions for brain surgery, including stereotactic systems and real-time imaging guidance technologies. The company enables neurosurgeons to perform precise interventions for conditions including movement disorders, epilepsy, pain management, and brain tumors.

Cognixion develops brain-computer interface technology designed to restore communication and control for individuals with paralysis and motor impairments. The company's noninvasive neural interface systems enable users to control digital devices and communicate through thought alone.

COGNOTICA develops neurotechnology solutions that integrate advanced computational methods with neuroscience research to enhance cognitive assessment and brain-computer interface applications. The company serves clinical, research, and commercial sectors with tools designed to improve neurological diagnostics and cognitive performance monitoring.

Connectome Health develops neuroimaging analysis software and computational tools designed to map and analyze neural connectivity patterns for research and clinical applications. The company's technology enables healthcare organizations and research institutions to extract actionable insights from connectome data to support neuroscience research and patient care optimization.

Control Bionics is an Australian neurotech company that develops brain-computer interface (BCI) technology enabling individuals with severe paralysis to control external devices through neural signals. The company's flagship system translates brain activity into commands for robotic limbs and communication devices, restoring functional independence to patients with conditions such as ALS and spinal cord injury.

curetec GmbH develops innovative medical device solutions and digital health technologies focused on neurological and neurorehabilitation applications. The company specializes in creating therapeutically effective technologies that integrate hardware and software to improve patient outcomes in neurology and rehabilitation medicine.

CVRx develops the Barostim system, a neuromodulation device that activates baroreceptors to treat heart failure and hypertension. The company's technology delivers electrical stimulation to the carotid sinuses to improve cardiovascular function and patient outcomes.

Deep Sleep Technologies develops advanced neurotechnology solutions designed to improve sleep quality and optimize sleep-related health outcomes. The company leverages neuroscience research and digital health platforms to deliver evidence-based interventions for sleep disorders and wellness.

Dendron Neurotechnologies develops neurotechnology solutions focused on advancing brain-computer interfaces and neural signal processing applications. The company's technologies are designed to enable new diagnostic and therapeutic capabilities in neuroscience research and clinical settings.

Divergence Neuro develops advanced neuroimaging and neuromodulation technologies for clinical and research applications. The company focuses on non-invasive brain imaging and therapeutic solutions to improve patient outcomes in neurological disorders.

DIXI medical develops and manufactures stereotactic frames and neurosurgical instruments for brain surgery and neuronavigation applications. The company specializes in precision tools used in functional neurosurgery, including devices for deep brain stimulation and lesioning procedures.

EB Neuro S.p.A. is an Italian medical device company specializing in neurophysiology and neuromonitoring equipment, including EEG systems, polysomnography devices, and intraoperative monitoring solutions. The company serves hospitals, clinics, and research institutions worldwide with diagnostic and monitoring technologies for neurological conditions.

Enspire DBS Therapy, Inc. develops deep brain stimulation (DBS) systems and therapies for the treatment of neurological disorders including Parkinson's disease, essential tremor, and dystonia. The company focuses on advancing neuromodulation technology to improve patient outcomes and quality of life through innovative DBS solutions.

Excellent Brain develops neurotechnology solutions focused on brain health and cognitive performance optimization. The company offers products and services designed to enhance neural function through evidence-based approaches.

First Responder Neurofeedback, Inc. provides neurofeedback training and brain-based interventions designed specifically for first responders and emergency personnel. The company develops and delivers evidence-based neurotechnology solutions to address stress, trauma, and cognitive performance challenges common in high-risk professions.

g.tec medical engineering GmbH develops brain-computer interface (BCI) technology and neuromonitoring systems for medical, research, and assistive applications. The company designs hardware and software solutions for real-time neural signal acquisition, processing, and analysis across clinical and research environments.

Headway Health offers acupuncture, bioenergetics, and neurofeedback services designed to support neurological wellness and optimize brain function. The company combines traditional therapeutic approaches with modern neurotechnology to address patient health concerns through non-invasive treatment modalities.

Healium is a digital therapeutics platform that uses immersive technologies, including virtual and augmented reality, to deliver clinically-validated interventions for anxiety, stress, and other mental health conditions. The company's brain-controlled experiences enable users to monitor and manage their emotional states through real-time biofeedback mechanisms.

IDUN Technologies develops wearable biosensing devices and software platforms that capture physiological data for applications in health monitoring, research, and enterprise wellness. The company's technology enables real-time collection and analysis of biometric signals to support clinical insights and behavioral health management.

INBRAIN Neuroelectronics develops implantable neuroelectronic devices designed to treat neurological disorders through targeted brain stimulation and neural recording technologies. The company focuses on creating minimally invasive solutions for conditions such as Parkinson's disease, epilepsy, and chronic pain.

Invictus BCI Incorporated develops brain-computer interface (BCI) technologies designed to restore communication and motor function for individuals with neurological conditions. The company focuses on translating neuroscience research into practical therapeutic solutions for patients with paralysis and severe motor impairment.

Koniku develops biological computing systems that leverage living neurons to create intelligent processing platforms for real-time sensing and analysis applications. The company's technology enables faster, more energy-efficient computation by harnessing the natural capabilities of neural networks at the cellular level.

Macrotellect-Brainwave Technology & BrainLink develops brain-computer interface solutions and neurotechnology applications designed to enhance cognitive function and neural connectivity. The company specializes in brainwave analysis and neurotech products that bridge human cognition with digital systems.

Mendi develops wearable neurotechnology devices that provide real-time biofeedback to help users optimize cognitive performance and mental state. The company's flagship product uses near-infrared spectroscopy to measure brain activity and deliver actionable insights for improved focus and well-being.

MindMaze Therapeutics develops neurotechnology solutions for neurological and psychiatric disorders through brain-computer interfaces and digital therapeutics. The company focuses on restoring motor and cognitive function in patients with conditions such as stroke, spinal cord injury, and neuropsychiatric disorders.

myflow by MindMetrix AG is a neurotechnology platform that leverages brain-computer interface (BCI) technology to optimize cognitive performance and mental wellness. The company develops software solutions designed to enhance focus, productivity, and emotional regulation through real-time neural feedback and personalized interventions.

NeuFit develops neuromuscular electrical stimulation (NMES) technology and wearable devices designed to optimize muscle performance and recovery. The company's platform integrates biofeedback and electrical stimulation to support athletic training, rehabilitation, and physical therapy applications.

Neuralink is a neurotechnology company developing implantable brain-computer interfaces designed to enable direct communication between the human brain and computers. The company focuses on creating safe, high-bandwidth neural interface systems to treat neurological conditions and enhance human cognitive capabilities.

NeurAlive Counselling & Neurofeedback provides clinical counselling services integrated with neurofeedback therapy to address mental health and neurological concerns. The organization utilizes evidence-based neurofeedback protocols alongside traditional counselling to help clients achieve improved emotional regulation and cognitive function.

Neurawear develops wearable neurotechnology devices designed to monitor and interface with neural activity. The company's products enable real-time brain data collection for applications in health monitoring, cognitive performance, and neuroscience research.

neurocare group develops and commercializes neuromodulation devices and software solutions for treating neurological and psychiatric disorders. The company offers a range of products including transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) systems for clinical and research applications.

Neuromod develops non-invasive neuromodulation devices and therapies designed to treat neurological and psychiatric conditions. The company's technology platforms focus on delivering targeted stimulation to address disorders including tinnitus, depression, and other neurological conditions.

NeuroPace develops an implantable neurostimulation system designed to treat drug-resistant epilepsy by detecting and responding to abnormal brain activity in real time. The company's RNS System is FDA-approved and represents an advanced therapeutic option for patients who do not respond to conventional anti-seizure medications.

Neurosity develops consumer-grade brain-computer interface headsets that enable real-time EEG monitoring and neural signal processing for applications in wellness, gaming, and productivity. The company's platform allows developers to build applications that interpret brainwave data for cognitive state detection and user experience personalization.

NeuroSky develops non-invasive brain-computer interface technologies and biosensing platforms that measure and interpret brainwave activity for consumer and enterprise applications. The company's products enable real-time neural data collection for applications in wellness, gaming, education, and research.

Neurosoft Bioelectronics develops bioelectronic devices and technologies that integrate neural interfaces with advanced electronic systems for medical and research applications. The company specializes in creating innovative solutions that bridge neuroscience and engineering to enable direct communication between biological and electronic systems.

NeuroVP is a specialist in neurofeedback technology and training, offering evidence-based neurofeedback solutions for cognitive and behavioral optimization. The company provides professional neurofeedback services and expertise through their platform at neurovp.eu.

NeuroFlux develops brain-computer interface (BCI) technology and neural signal processing software for medical and research applications. The company's platforms enable real-time monitoring and interpretation of neural activity to support therapeutic interventions and neuroscience research.

Omniscient Neurotechnology (o8t) develops neurotechnology solutions that integrate neural interfaces with data analytics and artificial intelligence. The company focuses on applications in brain-computer interfaces and neuroscience research tools accessible through their platform at o8t.com.

ONWARD Medical develops implantable neuromodulation technologies designed to restore mobility and function in individuals with spinal cord injury through targeted electrical stimulation. The company's proprietary systems combine neural engineering with clinical expertise to enable therapeutic interventions that promote neurological recovery.

OpenBCI develops open-source brain-computer interface (BCI) hardware and software platforms that enable researchers, developers, and enthusiasts to create neurotechnology applications. The company provides affordable, accessible tools for electroencephalography (EEG) and electrocorticography (ECoG) signal acquisition and processing.

Opsin Biotherapeutics, Inc. develops optogenetic-based therapies that use light-sensitive proteins to treat neurological and ophthalmological disorders. The company leverages proprietary technology to enable precise neural modulation for conditions including retinal degeneration and neurological diseases.

Oxford Brain Diagnostics Ltd develops advanced neuroimaging analysis and diagnostic tools for brain disorders. The company provides software solutions designed to improve the accuracy and efficiency of clinical decision-making in neurology and psychiatry.

OYMotion Technologies Co., Ltd develops electromyography (EMG) sensing technology and gesture recognition solutions for human-machine interaction applications. The company specializes in wearable biosensing devices that enable intuitive control of consumer electronics, robotics, and virtual reality systems through muscle signal detection.

Providence Therapy & Neurofeedback offers therapeutic and neurofeedback services designed to address neurological and behavioral health concerns. The clinic utilizes evidence-based neurofeedback training and therapy modalities to support clients in achieving improved cognitive and emotional functioning.

Reliefband Technologies LLC develops wearable neurotech devices designed to alleviate nausea and vomiting through proprietary nerve stimulation technology. The company's FDA-cleared products target motion sickness, chemotherapy-induced nausea, and post-operative nausea relief.

Remedee Labs develops non-invasive neuromodulation devices designed to provide drug-free pain relief and symptom management through wearable technology. The company's platform delivers targeted stimulation to address chronic pain conditions and improve patient quality of life without pharmaceutical intervention.

ReVision Implant develops retinal implant technology designed to restore vision in patients with retinal degenerative diseases. The company's bionic eye system aims to provide functional sight restoration through advanced neural interfacing and image processing.

Rice University is a private research institution located in Houston, Texas, offering undergraduate and graduate programs across engineering, science, humanities, and social sciences. The university conducts extensive research in neurotechnology and related fields through its departments and interdisciplinary centers.

Saluda Medical develops implantable neuromodulation devices that use closed-loop technology to deliver targeted therapy for chronic pain and movement disorders. The company's proprietary sensing and stimulation platform enables personalized treatment by continuously monitoring neural activity and adjusting stimulation parameters in real time.

Salvia BioElectronics develops bioelectronic devices and technologies that interface with biological systems for therapeutic and diagnostic applications. The company focuses on advancing neuromodulation and biocompatible electronic solutions for medical treatment.

SensorStim Neurotechnology GmbH develops neurotechnology solutions focused on sensory stimulation and neural interfacing applications. The company provides products and services designed to advance research and clinical applications in neurotechnology.

SkyBrain Neurotech develops neurotechnology solutions focused on brain-computer interfaces and neural applications. The company operates through its primary web presence at skybrain.in, serving the neurotech industry with innovative technology development.

Sooma Medical develops transcranial magnetic stimulation (TMS) devices for the treatment of depression and other neurological conditions. The company offers both clinical systems and integrated software solutions designed to enhance treatment efficacy and patient outcomes.

Soterix Medical develops non-invasive neuromodulation devices and systems, including transcranial direct current stimulation (tDCS) technology for clinical and research applications. The company provides FDA-cleared medical devices and software platforms designed to advance neurological treatment and brain research.

Abbott is a global healthcare company that develops, manufactures, and distributes pharmaceuticals, medical devices, diagnostics, and nutritional products across multiple therapeutic areas. The company serves healthcare professionals and patients in more than 160 countries with a focus on improving health outcomes through innovative technologies and treatments.

BrainBoost develops neurotechnology solutions designed to enhance cognitive performance and brain health. The company's offerings leverage neuroscience research to deliver products and services targeting mental optimization and neurological wellness.

Braincode Centers provides neurofeedback and biofeedback training services designed to optimize brain function and support mental health outcomes. The company offers evidence-based protocols for addressing conditions including ADHD, anxiety, depression, and sleep disorders through non-invasive neuromodulation techniques.

Brainstim Centers, Inc. provides transcranial magnetic stimulation (TMS) and other neuromodulation therapies for the treatment of depression and related neurological conditions. The company operates clinical centers offering FDA-cleared brain stimulation treatments administered by qualified medical professionals.

Bright Wave develops neurotechnology solutions focused on advancing brain-computer interfaces and neural signal processing. The company's platform enables researchers and clinicians to better understand and interact with neural systems for therapeutic and research applications.

Cephalogics delivers closed-loop neurofeedback therapy via a wearable headband that trains attention and stress resilience in real time using personalized EEG-driven protocols.

Cleveland Neurofeedback provides neurofeedback therapy services utilizing real-time brain activity monitoring to help clients self-regulate neural patterns and address various neurological and psychological conditions. The practice offers evidence-based neurofeedback training delivered by qualified practitioners to support cognitive function, emotional regulation, and overall brain health.

Frisco Neurofeedback is a neurofeedback provider offering brain training and EEG-based biofeedback services to help clients optimize cognitive performance and address neurological concerns. The company utilizes real-time neurophysiological monitoring to deliver personalized neurofeedback protocols.

Hutton Neurofeedback provides neurofeedback training and brain-based assessment services designed to optimize cognitive and emotional function. The company offers evidence-based protocols for addressing conditions such as ADHD, anxiety, and sleep disorders through real-time brain activity monitoring and feedback.

LivaNova is a global medical device company specializing in neuromodulation and cardiac surgery solutions, with a focus on vagus nerve stimulation therapy for epilepsy, depression, and heart failure. The company develops and manufactures innovative implantable devices and cardiopulmonary products for patients worldwide.

Medtronic is a global medical technology company that develops, manufactures, and markets devices and therapies for chronic diseases, including cardiac, vascular, neurological, and diabetes conditions. The company serves healthcare systems, physicians, and patients across more than 160 countries with innovative solutions for patient monitoring, drug delivery, and surgical interventions.

Mynd Analytics uses quantitative EEG biomarkers and machine learning to predict psychiatric medication response and guide treatment decisions for depression and anxiety.

Neurofeedback Luxembourg provides neurofeedback training services designed to help clients optimize brain function and improve cognitive performance through real-time brain activity monitoring and feedback. The company specializes in evidence-based neurofeedback protocols tailored to address attention, focus, and neurological wellness objectives.

Neurogenix Therapeutics develops small-molecule neurotrophin mimetics targeting TrkB receptors to treat treatment-resistant depression and cognitive decline.

Neurotech, LLC develops electroencephalography (EEG) technology and neurotechnology solutions for clinical and research applications. The company provides hardware and software systems designed to support neurological monitoring and brain-computer interface development.

Neurvana Health develops digital therapeutics and cognitive behavioral therapy solutions for mental health and neurological conditions. The company's platform delivers evidence-based interventions through mobile and web applications to improve patient outcomes and accessibility to mental health care.

Optiminds Brain Training offers cognitive enhancement programs designed to improve mental performance and neuroplasticity through scientifically-based exercises and training methodologies. The company provides brain training solutions targeting memory, attention, processing speed, and other cognitive functions for individual and organizational clients.

Peak Brain Institute provides comprehensive neuropsychological testing, cognitive assessment, and brain health evaluation services in the Los Angeles area. The institute specializes in diagnosing and treating neurological and cognitive conditions across the lifespan.

Summit Brain Health provides comprehensive neurological and brain health services through a multidisciplinary team of specialists. The practice focuses on diagnosis, treatment, and management of neurological disorders to optimize patient outcomes.

Sunshine Neurofeedback provides neurofeedback training services designed to help clients improve attention, emotional regulation, and overall brain performance through real-time brain activity monitoring and feedback. The company offers customized neurofeedback protocols delivered by trained practitioners to support cognitive and behavioral health goals.

Traumatic Brain Diagnostics develops diagnostic tools and solutions for the assessment and evaluation of traumatic brain injuries. The company provides healthcare professionals with technology designed to improve TBI detection and clinical decision-making.

Augmental develops MouthPad, a tongue-controlled trackpad that sits inside the mouth, enabling hands-free device control through intuitive neural-muscular interface technology.

Cadwell manufactures clinical neurophysiology equipment including EEG, EMG, evoked potentials, and intraoperative neuromonitoring systems for hospitals and research institutions worldwide.

deCervo applies neuroscience and machine learning to measure and improve cognitive performance, with applications in sports performance assessment and concussion evaluation.

HippoScreen develops AI-powered cognitive screening tools for early detection of memory disorders and neurodegenerative diseases, enabling rapid assessment in clinical settings.

Memcara develops neurotechnology solutions focused on memory and cognitive health assessment and intervention. Their platform supports early detection and monitoring of neurological conditions.

Mind Alive manufactures audio-visual entrainment and cranio-electro stimulation devices designed to improve mood, sleep, relaxation, and cognitive performance through light and sound stimulation.

Neurolief develops non-invasive neuromodulation devices for the treatment of neurological and psychiatric conditions, including migraine and depression, using targeted electrical stimulation.

neuromore is a digital health platform for real-time biofeedback and neurofeedback, enabling developers and clinicians to build brain-computer interface applications using a visual programming environment.

Neurovalens develops non-invasive vagus nerve stimulation wearables for improving sleep, reducing anxiety, and managing metabolic health through targeted neural stimulation.

Parley Neurotech develops innovative neurotechnology solutions for clinical and consumer applications in the brain health space.

Pulsetto makes a wearable vagus nerve stimulation device designed to reduce stress, improve sleep, and enhance recovery through non-invasive neuromodulation technology.

Qualia Life Sciences develops science-based nootropic supplements and cognitive enhancement products designed to optimize brain performance, focus, and mental clarity.

Solvemed develops the PuRe Pupillometer, an AI-powered pupillometry platform that uses smartphone cameras to measure pupil responses as objective biomarkers for neurological assessment and drug monitoring.

Synapticure is a precision medicine company focused on genetic neurological diseases, offering genetic testing, genetic counseling, and care navigation for patients with conditions like ALS, FTD, and Parkinson's disease.

Synchroni develops biosensing hardware and software for brain-computer interface applications, providing high-quality EEG streaming and neural signal processing for researchers and developers.

Voxela develops AI-powered neuroimaging analysis software for clinical neurology and neuroscience research applications. Their platform enables real-time brain imaging interpretation and diagnostic support for clinicians.

Actipulse Neuroscience develops neuromodulation technology designed to treat brain disorders including depression and Alzheimer's disease through innovative brain health solutions. The company leverages advanced neurotech platforms to advance life sciences research and clinical applications in neuromodulation therapy.

Actuated Medical, Inc. develops FDA-cleared brain implant technologies that combine hardware and software solutions to address critical clinical needs in patient care and outcomes. The company leverages a medical advisory board and expertise in medical equipment manufacturing to deliver innovative neurotechnology solutions that advance patient care.

Altoida develops AI-powered digital biomarker technology using augmented reality and machine learning to detect and monitor neurodegenerative diseases, particularly dementia, through mobile health applications. The company's platform transforms smartphones and tablets into clinical-grade diagnostic tools that measure brain health by analyzing cognitive and functional performance metrics.

Ananda Devices develops advanced cell culture and organ-on-chip technologies that enable preclinical neuroscience research and drug development for neurological diseases including myasthenia gravis and Alzheimer's. The company's platform uses stem cell-derived neurons to provide sophisticated in vitro models for accelerating the discovery and testing of therapeutic candidates.

Anatomic Incorporated develops off-the-shelf neural cells derived from pluripotent stem cells for biotechnology research and disease modeling applications. The company specializes in neuron differentiation, cell cryopreservation, and creating neurodegenerative disease models including demyelination screening platforms.

Anthriq develops neurotechnology solutions that leverage analog processing and biosignal analysis to advance brain-computer interface applications and EEG-based research. The company focuses on biotechnology innovations that enable more efficient and accurate processing of neurological data for scientific and medical applications.

Apollo Neuro develops a wearable neurotech device that uses subtle haptic stimulation to help users manage stress, improve sleep, and enhance focus through non-invasive neuroscience-based technology. The company's digital health platform delivers personalized wellness and fitness solutions designed to optimize sleep quality and support overall stress relief for consumers seeking science-backed health interventions.

Arctop develops advanced biometric authentication solutions leveraging computational neuroscience and machine learning to create secure, user-friendly identity verification systems. The company's technology combines data science and cybersecurity expertise to deliver next-generation authentication experiences for enterprise and consumer applications.

Attune Neurosciences develops non-pharmaceutical brain health monitoring solutions and wearable technology designed to track performance biometrics and support depression therapy through advanced neurotech innovation. The company's sleep-ready wearables and cell-type optimization approaches enable consumers to optimize brain health and wellness through science-backed biometric monitoring and personalized treatment recommendations.

Axoft develops biocompatible hydrogel neural interfaces with ultra-high electrode density enabling single-neuron resolution recording and stimulation of the nervous system. The company provides B2B neurotech solutions including surgical implantation tools and wireless neural data transmission systems designed for seamless nervous system integration through nanotechnology research.

Axonis Therapeutics is a biotechnology company developing gene therapy treatments for spinal cord injury and neurological disorders using AAV vectors and shRNA technology to promote axon regeneration and neuroprotection. The company leverages advanced drug discovery platforms focused on regenerative medicine to address currently untreatable central nervous system injuries.

Bearmind develops advanced brain modeling technology and wearable devices designed to assess impact severity and monitor outcomes for individuals with traumatic brain injuries. The company combines neuroscience expertise with medical equipment manufacturing to create innovative solutions for injury detection and management.

Bioscan Research develops AI-powered point-of-care diagnostic devices that enable non-invasive brain monitoring and traumatic brain injury assessment using near-infrared spectroscopy technology. The company specializes in portable medical innovations designed for emergency prehospital neurocare and rapid neurological evaluation in resource-limited settings.

Blackrock Neurotech develops advanced brain-computer interfaces (BCIs) and neural monitoring systems that enable direct communication between the brain and external devices to restore mobility and sensory function. The company's microelectrode array technology and neurophysiology expertise support innovative medical applications for individuals with paralysis and neurological conditions.

BRAIN.Q develops frequency-tuned electromagnetic therapy devices designed to promote neurogenesis and support neurorepair in patients recovering from neurological conditions such as stroke. The company conducts clinical trials and research to validate its medical device technology for use in health and human services applications.

BrainCapture develops AI-powered EEG monitoring solutions designed to detect and manage epilepsy through advanced machine learning algorithms. The company manufactures medical devices that enable real-time seizure detection and telemedicine capabilities, integrating cutting-edge neurological technology into clinical and remote healthcare settings.

BrainKey leverages artificial intelligence and advanced MRI analysis to provide preventive analytics for brain health and neurological conditions. The company's platform enables early detection and personalized insights to support longevity and proactive healthcare management.

BrainZell develops advanced cell-based models using induced pluripotent stem cells to enable biotechnology research, target validation, and neural activity testing for drug development. The company specializes in long-term exposure studies and high-throughput drug discovery platforms designed to accelerate the identification and optimization of therapeutic candidates.

CEFALY Technology manufactures FDA-cleared neuromodulation devices that deliver drug-free migraine prevention and treatment through transcranial stimulation technology. The company's direct-to-consumer platform offers clinically validated preventive therapy solutions backed by extensive clinical studies demonstrating efficacy in migraine management.

Clarity is a neurotech company specializing in medical equipment manufacturing and AI-driven brain models designed to advance neuroprotection and cognitive enhancement through innovative approaches including VR-based gamma stimulation. The company conducts clinical trials and provides services leveraging foundation models and cutting-edge neurotechnology to support brain health applications.

CoMind develops advanced brain-computer interface technology combining neuroimaging, wearable sensors, and machine learning to enable direct communication between the human brain and external devices. The company manufactures specialized medical hardware utilizing infrared laser technology to support neuroscience research and clinical applications.

CorTec is a neurotechnology company specializing in the development and manufacturing of innovative medical devices and neurotechnological implants for research and clinical applications. The company provides B2B services and implant components designed to advance stroke rehabilitation and other neurological treatments.

Creyos is a neurotech company that provides objective cognitive assessment and testing solutions to measure and track brain health across multiple cognitive domains. The platform enables hospitals, healthcare providers, and research institutions to quantitatively monitor cognitive health and support clinical decision-making through scientifically validated assessments.

Curonix develops wireless neurostimulation technology for pain management, specializing in spinal cord and peripheral nerve stimulation systems. The company manufactures integrated hardware and software medical equipment, including external transmitter assemblies designed to deliver targeted neuromodulation therapy.

Darmiyan develops machine learning-powered diagnostic solutions for early detection and monitoring of brain health conditions, including mild cognitive impairment, utilizing advanced radiology analysis on cloud-based platforms. The company's technology enables healthcare providers to support brain longevity and cognitive health through AI-driven screening and continuous patient monitoring.

EMOTIV develops scientific-grade EEG (electroencephalography) systems and brain monitoring solutions that capture and analyze brain activity data for applications spanning education, healthcare, industrial safety, and research. The company's neurotech platform combines wearable EEG hardware with advanced bioinformatics software to provide real-time brain health insights and contextual analysis for both consumer and enterprise markets.

Engrail Therapeutics is a biotechnology company focused on drug discovery and development for neurodevelopmental disorders, leveraging advanced pharmacokinetic approaches to create innovative pharmaceutical solutions. The company combines life sciences expertise with pharmaceutical manufacturing capabilities to advance novel therapeutics that address unmet medical needs in the neurotech sector.

Fisher Wallace Laboratories, Inc. is a neurotech company that develops and manufactures the Fisher Wallace Stimulator, a FDA-cleared cranial electrotherapy stimulation (CES) device designed to treat conditions including depression, anxiety, insomnia, and chronic pain disorders. The company's non-invasive technology is used to address stress management, fibromyalgia, migraines, phantom limb pain, and other neurological conditions through neurostimulation therapy.

General Sense is developing the world's first nose-computer interface, leveraging neurotechnology and machine learning to create artificial intelligence-powered olfaction detection systems. The company's technology enables enhanced working animals and represents a novel brain-computer interface application in the sensory neurotechnology sector.

Great Lakes NeuroTechnologies develops digital health solutions for neurological disease monitoring, specializing in wearable biosensors and motion capture technology for remote patient assessment and management. The company's platforms enable telemedicine-based monitoring of motor symptoms and physiological signals, with particular applications in Parkinson's disease management through wireless physiological monitors and advanced biosignal processing.

Harness Therapeutics is a biotechnology company developing RNA-based therapeutic approaches to treat neurodegeneration through proprietary technologies including antisense oligonucleotides (ASOs), mRNA therapeutics, and SINEup-based posttranscriptional upregulation strategies. The company focuses on leveraging physiological upregulation mechanisms to create innovative treatments for neurodegenerative diseases.

Hylomorph develops advanced neurostimulation and implantable medical devices incorporating innovative biomaterials designed to prevent infections across multiple surgical specialties including electrophysiology, cardiac surgery, and plastic surgery. The company's medical technology platform addresses critical challenges in device safety and biocompatibility for patients requiring neurostimulation therapies.

iMotions is a neurotech platform that integrates EEG, biosensors, and eye-tracking data with traditional research methods to measure human behavior and emotional responses in real-time. The company provides tools for shelf testing, scientific research, and consumer insights through APIs and survey capabilities, serving researchers and businesses seeking objective behavioral data.

Inner Cosmos develops personalized brain therapy solutions as a non-invasive alternative to traditional TMS treatments for depression, leveraging biotechnology research and clinical trials to deliver targeted outpatient interventions. The company works with physicians' offices to provide evidence-based depression treatment through innovative neurotech approaches designed to improve patient outcomes.

Invenio Imaging develops advanced intraoperative imaging solutions using stimulated Raman histology and AI to provide real-time pathological visualization during surgical procedures. The company's technology enables surgeons to identify brain tumors, lung lesions, and other tissue abnormalities with enhanced precision during interventional pulmonology and neurosurgical interventions.

iota Biosciences develops implantable neurotech devices and brain-machine interfaces using ultrasound and bioengineering innovations to create nerve interfaces for bioelectronic medicine applications. Powered by Astellas, the company advances the field of neuroengineering through cutting-edge implantable medical device technologies designed to restore neural function and treat neurological conditions.

JOGO Health develops digital therapeutics to treat neurological conditions and associated symptoms including Bell's palsy, cerebral palsy, spinal cord injury, and cancer pain. The company's platform addresses both motor and functional impairments such as pain, constipation, and fecal incontinence through technology-enabled therapeutic interventions.

Karuna Labs develops immersive virtual and augmented reality technologies for chronic pain management and neurological health applications. The company leverages neuroscience and digital health innovations to create therapeutic solutions that improve patient outcomes in the life sciences and healthcare sectors.

Longeviti Neuro Solutions develops innovative functional neurosurgical devices and medical equipment that integrate advanced technologies including laser technology, robotics, and ultrasound imaging to treat neurologic disorders. The company specializes in navigation systems and cranial reconstruction solutions designed to enhance precision in neurosurgical procedures.

Magnus develops MRI-guided transcranial magnetic stimulation (TMS) technology that delivers personalized neuromodulation for mental health and brain health applications through advanced brain circuit modulation. The company manufactures medical equipment designed to restore brain connectivity and improve safety profiles in targeted brain stimulation treatments.

Mobia Medical develops innovative neurotech medical devices designed to advance treatment options in neuroscience and healthcare. The company specializes in medical equipment manufacturing for life sciences applications, focusing on delivering cutting-edge solutions for clinical and patient care needs.

Modulight Biotherapeutics is a biotechnology company specializing in optogenetics and optogenetic gene delivery technologies for advanced therapeutic applications. The company combines engineering and life sciences research and development to create innovative neurotech solutions designed to disrupt the treatment landscape.

Motif Neurotech designs and manufactures minimally invasive bioelectronic devices for brain stimulation, advancing the neurotech innovation ecosystem through cutting-edge medical device technology. The company specializes in neural network activation therapies as part of the broader medical equipment and supplies manufacturing sector, delivering innovative healthcare solutions.

MyelinZ® develops advanced neurotechnology solutions that integrate machine learning and artificial intelligence to advance brain-computer interface applications across medical, gaming, and aerospace sectors. The company specializes in medical equipment manufacturing and brain health innovations, leveraging cutting-edge AI to create next-generation neurotech products.

Myndlift is a digital health company that develops neurofeedback solutions delivered through mobile applications to support ADHD management and brain health optimization. The platform combines healthcare technology with education-focused tools to help users monitor and improve neurological function through evidence-based neurofeedback interventions.

NeuraSignal develops AI-powered ultrasound technology for real-time neurological diagnosis and stroke detection, enabling clinicians to identify critical conditions at the point of care. The company leverages advanced data science and cloud-based analytics to deliver rapid, accurate neurological assessments that improve patient outcomes in acute care settings.

NeuroAge Therapeutics is a biotechnology company focused on developing AI-powered solutions for cognitive health and brain aging reversal through advanced research and drug development. The company combines neuroscience expertise with artificial intelligence-driven brain testing technologies to create therapeutics aimed at addressing age-related neurological decline.

NeuroBionics develops minimally invasive fiber-based neural interfaces and neuromodulation medical devices that leverage biocompatible materials to advance neurotechnology innovation. The company combines neuroscience expertise with biotechnology research to create next-generation neural interface solutions for therapeutic applications.

Nia Therapeutics develops neural implant technology and brain signal classification systems designed to treat memory loss and other neurological conditions through AI-driven therapy optimization. The company manufactures medical devices that combine neural sensing technology with advanced algorithms to enable personalized, adaptive treatment approaches for patients with cognitive disorders.

Noctrix Health, Inc. is a medical device startup specializing in neurotechnology solutions for sleep disorder management and patient-centered care. The company manufactures innovative sleep aid technology and medical equipment designed to improve outcomes for patients with sleep-related conditions.

Oculogica develops neurodiagnostic medical devices that utilize eye-tracking technology to detect and assess brain injuries, including concussions and traumatic brain injuries (TBI). The company's innovative platform provides objective, rapid diagnostic capabilities for healthcare providers to identify neurological impairment and support patient management decisions.

ONI develops advanced desktop super-resolution microscopy systems enabling single-molecule imaging and tracking of neurons with exosome-level localization precision. Their PALM and dSTORM-based platforms provide researchers with accessible, high-performance tools for studying cellular and neuronal dynamics at the nanoscale.

Openwater develops non-invasive neurotech medical devices using advanced ultrasound and laser technologies combined with AI software to enable real-time imaging and monitoring of brain activity. The company conducts clinical studies to advance its hard tech platform for medical device manufacturing and therapeutic applications in neuroscience.

OptoCeutics develops advanced light-based medical devices that leverage artificial intelligence and machine learning to deliver targeted therapeutic treatments, including proprietary 40 Hz light therapy technology for neurological applications. The company combines cutting-edge neuroscience research with medical device innovation to create non-invasive treatment solutions that harness the power of light for therapeutic benefit.

Paradromics develops advanced brain-computer interface (BCI) technology, including its Direct Data Interface (DDI) platform, designed to create high-bandwidth neural interfaces for assistive communication and neuroscience applications. The company's neurotechnology solutions aim to restore communication and mobility capabilities for individuals with severe neurological conditions.

PD Neurotechnology Ltd. develops sensor-based medical software solutions for objective movement disorder diagnostics and remote neurological assessment, enabling quantified symptom monitoring and disease progression tracking. The company supports clinical research and trials through innovative healthcare technology that facilitates objective, data-driven evaluation of neurological conditions.

PHOSPHOENIX is a neurotechnology company specializing in the development and manufacturing of ultra-flexible, high-density neural probes for preclinical research applications. The company provides advanced research services and medical equipment designed to enable ground-breaking neuroscience studies through innovative probe technology.

Piramidal is a neurotechnology company developing AI-powered EEG diagnostics and brain health monitoring solutions for pharmaceutical and clinical applications. The company leverages deep learning algorithms to analyze neurological data, enabling improved diagnosis and monitoring of neurological conditions.

Pison develops neurotechnology software that translates brain signals into actionable insights for cognitive and sports performance optimization. The company provides neurophysiological data collection and analysis tools designed to advance neuroscience research while delivering real-time health metrics and performance monitoring for athletes and professionals.

Precision Neuroscience develops advanced brain-computer interface (BCI) technology, including the Layer 7 cortical interface, for neurological applications and neuroscience research. The company manufactures medical devices and equipment designed to enable precise neural signal recording and interpretation for clinical and research purposes.

Prilenia is a biopharmaceutical company focused on developing neuroprotective therapies targeting the sigma-1 receptor for neurodegenerative and neuropsychiatric diseases. The company combines drug development expertise with global operations to advance disease-modifying treatments and ensure patient access to innovative neurological therapies.

QMENTA is a neurotech company that develops AI-powered clinical trial platforms leveraging machine learning and deep learning to accelerate drug discovery and neuroimaging analysis. The company's solutions enable pharmaceutical companies and research institutions to optimize clinical trials through advanced artificial intelligence and data management capabilities.

RxFunction, Inc. develops wearable neuromodulation technology and mobile solutions designed to assess and treat peripheral neuropathy through real-time gait analysis and mobility monitoring. The company combines wearable sensors with cloud-based analytics to deliver personalized neurotech interventions that improve patient outcomes and clinical decision-making.

ShiraTronics, Inc. is a medical equipment manufacturer specializing in neuromodulation technologies and neurostimulation devices designed for therapeutic applications including headache treatment. The company conducts neuromodulation research and clinical studies to advance treatment options in the neurotech field.

Synaptrix is a neurotech company specializing in brain-computer interface (BCI) technology, leveraging deep learning and artificial intelligence to advance neuroscience research and neurodiagnostics. The company develops innovative solutions for EEG-to-text conversion and other biomedical engineering applications at the intersection of biotechnology, AI, and neuroscience.

Syntropic is a medical equipment manufacturer specializing in clinical neurotechnology and neuroimmune therapy designed to repair brain circuits and promote brain health through non-invasive treatment approaches. The company focuses on therapeutic interventions targeting perineuronal nets and related neural structures to address neurological conditions.

Tetraneuron is a neurotech company developing disruptive therapies and biomarkers for neurodegenerative diseases including Alzheimer's and other forms of neurodegeneration. The company focuses on gene therapy approaches to address the underlying causes of dementia and progressive neurological disorders.

Vagustim is a neuromodulation company developing vagus nerve stimulation technology to treat autonomic nervous system disorders including headaches, tinnitus, and autonomic dysfunction. The company's platform leverages non-invasive stimulation techniques to modulate neural pathways and restore autonomic balance in patients suffering from related conditions.

Adeption is an AI-powered leadership training platform that delivers coaching and vertical leadership development programs designed to maximize ROI through measurable outcomes and performance tracking. The company specializes in high-impact training solutions that help organizations grow and develop their people while demonstrating clear returns on training investments.

AdTonos is a programmatic audio advertising platform that enables native audio ad targeting and delivery across podcasts, streaming music, and digital audio channels using big data analytics. The company operates as a supply-side platform (SSP) providing advertisers and publishers with sophisticated tools for automated, data-driven audio ad campaigns.

Advanced Brain Monitoring develops clinical EEG solutions and sleep monitoring technologies that analyze sleep architecture and brain activity for biotechnology research and neuroscience applications. The company's sleep therapy devices and data analysis platforms support clinical research and treatment monitoring for neurodegenerative diseases and sleep disorders.

Advantis Medical Imaging develops cloud-based MR imaging technology that enhances diagnostic capabilities through advanced functional, perfusion, and diffusion MRI applications for healthcare providers. The company's medical device solutions streamline radiology workflows and improve clinical outcomes by delivering sophisticated imaging analysis through accessible cloud technology.

Adventist Health operates a comprehensive network of hospitals, clinics, home health services, and rural health clinics dedicated to providing quality healthcare and community wellbeing across multiple regions. The organization offers integrated services including hospice care and health education programs, serving patients through both clinical facilities and community-based health initiatives.

Afference, Inc. develops advanced neurotech solutions that integrate tactile feedback and artificial sensation technologies into spatial computing devices and virtual reality systems. The company specializes in neural signal processing and neural modulation to enable realistic touch replication and sensory perception in immersive digital environments.

AiM Medical Robotics develops advanced surgical robotic systems designed for precision neurosurgery and image-guided procedures, leveraging MRI technology to enable real-time intraoperative imaging and guidance. The company manufactures innovative medical equipment that integrates robotic automation with MRI-guided biopsy capabilities to enhance surgical accuracy and patient outcomes in neurological interventions.

AJNA BioSciences is a biopharmaceutical company focused on developing botanical drugs through rigorous scientific research and clinical validation. The company leverages plant medicine and biotechnology to advance a pipeline of botanical therapeutics while navigating regulatory pathways for clinical applications.

AjnaLens develops advanced computer vision and artificial intelligence software for smart glasses and extended reality devices, enabling intuitive spatial interaction through augmented, virtual, and mixed reality applications. The company specializes in 3D perception and real-time visual processing technologies that power next-generation wearable computing experiences.

Akrivia Health develops precision neuroscience solutions that leverage advanced data processing and mental health genomics to enable comparative effectiveness research and improve clinical outcomes. The company specializes in clinical notes processing, adverse event detection, and data enrichment while maintaining rigorous data security standards for biotechnology research applications.

Angeion Group is a specialized administration firm providing comprehensive support services for complex litigation matters, including class action and mass tort claims administration, legal noticing, and bankruptcy support. The company leverages multichannel communication strategies and litigation support expertise to serve attorneys, corporations, and stakeholders involved in large-scale legal proceedings.

Angelini Pharma is an Italian pharmaceutical manufacturer specializing in consumer healthcare, brain health, and mental health products, with a particular focus on epilepsy treatments and self-care solutions. The company leverages healthcare technology and strategic pharmaceutical partnerships to advance digital medicines and customer engagement in the neurotech sector.

Arctic Shores is a neurotech company specializing in psychometric games and behavior-based assessment software that evaluates soft skills and cognitive abilities for recruitment purposes. The platform uses serious games and gamified testing to enable skills-based hiring and provide data-driven insights into candidate potential beyond traditional recruitment methods.

Ariadne.ai ag develops deep learning and machine learning solutions for large-scale automated segmentation of biological ultrastructural features in electron and light microscopy images. The company's platform enables researchers to accelerate spatial biology, multiomics, and high-throughput screening applications through advanced image segmentation and data science capabilities.

Arrakis Therapeutics is a biotech company developing small-molecule drugs that modulate RNA binding proteins to address unmet medical needs through its proprietary chemical biology platform. The company leverages RNA target engagement technology to advance its RNA therapeutics pipeline and support pharmaceutical manufacturing of novel therapeutic candidates.

Aspen Neuroscience is a regenerative medicine biotech company developing autologous cell therapies using induced pluripotent stem cells (iPSCs) for neurodegenerative diseases, with a focus on Parkinson's disease. The company leverages genomics and personalized medicine approaches to create patient-specific treatments that aim to restore dopamine-producing neurons and halt disease progression.

Atom develops AI-powered prosthetic limbs and neural interface technology that enables intuitive control and real-time sensory feedback for users. The company combines advanced sensor technology with artificial intelligence hardware to create next-generation artificial limbs that restore natural movement and sensation for individuals with limb loss.

AVEA is a wellness and longevity company that develops bioavailable nutritional supplements and sleep support products designed to promote cellular rejuvenation and optimize human performance. The company combines clinical research with evidence-based formulations to support longevity goals, including participation in the Longevity XPRIZE initiative.

Aviv Scientific develops advanced neurorehabilitation technology and wellness programs that leverage the hyperoxic-hypoxic paradox to enhance brain performance and neuroplasticity through scientifically-designed physical training protocols. The company combines medical technology with evidence-based diagnostics to deliver personalized neurorehabilitation and fitness services aimed at optimizing cognitive function and physical recovery.

Backyard Brains is an educational neuroscience company that develops affordable DIY neuroscience kits and tools designed to make hands-on neuroscience experiments accessible to students and educators of all levels. Their consumer electronics and hardware products enable students to conduct real neuroscience research and engineering projects, making STEM education and neuroscience accessible outside traditional laboratory settings.

Baylor Scott & White Health is a comprehensive healthcare system offering specialized clinical services including heart and vascular care, rheumatology, endocrinology, critical care, and women's health alongside dedicated research initiatives. The organization focuses on advancing patient outcomes through strategic research projects and customer experience excellence across its rehabilitation, physical therapy, and allergy and immunology programs.

Bethany Children's Health Center provides comprehensive pediatric rehabilitation and transitional care services for children with complex medical needs through accredited outpatient and community-based programs. The organization specializes in pediatric orthopedics and complex care management, offering coordinated healthcare solutions designed to support children's development and family well-being.

BioCircuit Technologies manufactures innovative surgical devices designed to enhance neurosurgical efficiency and reduce operative time in clinical nerve repair procedures. The company develops advanced medical equipment that combines surgical innovation with practical solutions for improved patient outcomes in nerve repair applications.

BIOTRONIK is a global medical device company specializing in cardiac rhythm management systems, including implantable pacemakers (IPG), defibrillators (ICD), and cardiac resynchronization therapy (CRT) devices for patients with heart rhythm disorders. The company offers advanced home monitoring solutions and vascular intervention devices, enabling remote patient management and improving outcomes in cardiac care.

BioWave Corporation develops non-invasive nerve stimulation technology for pain management across diverse populations including athletes, veterans, and workers' compensation patients. The company's solutions serve pain clinics, physical therapy practices, and athletic trainers seeking drug-free alternatives for chronic and acute pain relief.

bit.bio is a biotechnology company that develops proprietary technology to create reproducible, high-quality cell batches for pharmaceutical drug discovery and cell therapy applications. The company's platform enables life science researchers and biotech organizations to standardize cell type generation at scale, supporting high-throughput screening and advancing biotechnology research.

Blueprint is a digital health platform founded by Bryan Johnson that leverages biomedical data and biomarker tracking to optimize human health and healthspan through personalized nutrition and performance monitoring. The company integrates advanced health monitoring technologies with scalable digital health systems to provide data-driven insights for individual wellness and longevity optimization.

Bottneuro AG develops advanced neuromodulation solutions and neurostimulation technologies for clinical and research applications. The company focuses on innovative approaches to treating neurological conditions through targeted stimulation of the nervous system.

BrainSightAI leverages artificial intelligence and machine learning to develop connectome-based diagnostic solutions that advance psychiatric and neurological treatment. The company applies deep technology innovations in neuroscience to deliver data-driven insights for hospitals and healthcare providers seeking to improve patient outcomes.

Breathe For Change develops mind-body wellness technology and curriculum designed to bring mindfulness and yoga practices into K-12 and higher education settings. The company provides yoga teacher training resources and digital solutions that support educators in fostering student mental health and wellbeing through evidence-based neuroscience and contemplative practices.

Brown University Health is a not-for-profit health system affiliated with Brown University that operates teaching hospitals and provides comprehensive healthcare services including primary care, behavioral health, cancer care, and pediatric medicine. The health system delivers integrated mental health services and specialized medical care across its network of facilities serving the Rhode Island region.

Buckeye Corrugated, Inc. specializes in innovative packaging and point-of-purchase display solutions, offering services ranging from simple one-color brown box designs to complex custom product packaging with digital printing capabilities. The company provides comprehensive support including retail pop displays, small countertop displays, assembly and fulfillment services, with a commitment to sustainable packaging practices.

Byteflies develops wearable neurotech sensors and AI-powered analytics for clinical applications, specializing in electroencephalography (EEG) and electrooculography (EOG) technologies to capture biomarkers from patients during clinical trials and real-world healthcare settings. The company's integrated hardware and software platform enables researchers and healthcare providers to monitor neurological activity and optimize patient outcomes through advanced data insights.

Caltech is a world-renowned research and educational institution located in Pasadena, California, known for its groundbreaking work in scientific innovation, biology research, and aerospace development, with numerous Nobel Prize winners among its faculty and alumni. The institute maintains significant collaborations with NASA on space mission planning and continues to advance neurotechnology and related scientific fields through cutting-edge research programs.

CereGate is a neurotech company specializing in the design and manufacturing of advanced neural interfaces and brain implants for treating movement disorders and other neurological conditions. The company provides comprehensive neurodiagnostic services and brain signal enhancement solutions, leveraging computer-brain interface technology to develop innovative medical devices and therapeutic solutions.

Cerenion Oy develops advanced qEEG software solutions for real-time brain function monitoring and patient assessment in critical care settings. The company's cTrend platform leverages machine learning algorithms to analyze electroencephalography data, enabling clinicians to make informed decisions about patient neurological status and outcomes.

Cerevance is a biotechnology company specializing in target discovery and identification for neurological diseases through advanced omics data analysis and biopharmaceutical research. The company leverages computational approaches to understand disease progression mechanisms and develop target-based therapeutic solutions for CNS disorders.

Cirtec Medical is a full-service contract manufacturer specializing in precision machining, Swiss turning, precision stamping, and surface mount technology for mechanical and electromechanical medical devices. The company offers vertically integrated manufacturing capabilities including electroformed devices and product transfer services to support neurotech and other medical device innovators.

Clario is a neurotech company specializing in AI-powered medical imaging and clinical solutions across cardiac, respiratory, and specialty applications. The company leverages precision motion technology and artificial intelligence to enhance clinical adjudication and diagnostic accuracy in medical imaging workflows.

CleverPoint Neuro develops advanced brain-computer interface and neurofeedback technologies that integrate biofeedback systems with virtual reality to provide objective physiological data for health monitoring and clinical applications. The company's solutions combine neuroscience with psychology and medicine to enable real-time neural feedback and performance optimization across medical and wellness domains.

Clinical Ink provides electronic data capture (EDC) and ePRO solutions designed to streamline clinical trials and life sciences research through digital patient engagement and real-time data collection. The company specializes in cognitive assessments and risk-based monitoring technologies, with particular expertise in therapeutic areas such as Parkinson's disease and other neurological conditions.

Clinilabs is a specialized clinical research organization providing comprehensive data management, medical writing, and early-phase research services with particular expertise in neurological disorders including Alzheimer's disease. The company facilitates Asian bridging studies and supports Phase I through Phase IIII clinical trials, offering tailored solutions for neurotech development and regulatory compliance.

Clouds of Care provides neurotech solutions for clinical development in sleep disorders and pediatric epilepsy, specializing in data acquisition, analysis, and regulatory-accepted endpoint validation. The company supports hospitals and healthcare organizations in de-risking CNS clinical trials through advanced endpoint validation methodologies.

CogniFit is a digital health company specializing in cognitive assessment, brain training, and brain fitness solutions that leverage scientifically-designed brain games and cognitive applications to support mental health and brain development. The company provides comprehensive cognitive evaluation tools and personalized brain training programs designed to help individuals maintain and improve their cognitive health across the lifespan.

Cognigenics is a biotechnology research company specializing in RNA therapeutics and precision genetic editing to develop genetic medicines targeting neurological disorders and cognitive impairment. The company focuses on hyperactive neuronal receptor research and utilizes advanced animal model testing to advance its therapeutic pipeline.

Cognitive Research Corporation provides specialized clinical research services for CNS drug development, including computerized cognitive testing, rater training and surveillance, and driving simulation assessments. The company supports pharmaceutical sponsors and CROs in Phase II-IV clinical trials through comprehensive neuroscience expertise and validated testing platforms.

Cognito Therapeutics develops non-invasive neuromodulation devices designed to modulate brain activity and support brain health through white matter preservation and brain plasticity enhancement. The company focuses on medical device solutions for neurodegenerative diseases, including Alzheimer's disease, with a mission to support brain function and cognitive health.

Coherence Neuro develops closed-loop neurotech systems that deliver targeted electrical stimulation guided by AI and machine learning algorithms to treat neurological conditions. The company manufactures medical devices for clinical applications and home-based care, leveraging real-time monitoring and neurobiology principles to optimize therapeutic outcomes.

Cooper University Health Care is an integrated healthcare system providing comprehensive medical services across multiple specialties including radiology, oncology, orthopedic joint replacement, and bariatric & metabolic surgery through its network of physicians and facilities. The organization operates a full-service hospital with urgent care capabilities, delivering patient-centered care throughout the region.

CorrActions develops advanced neurotech software solutions that monitor driver impairment and muscle micro-motions to enhance automotive safety and ADAS compliance through real-time EEG signal coupling technology. The company specializes in driver safety regulation systems and over-the-air vehicle updates designed to reduce accidents and support the evolving landscape of autonomous vehicle safety requirements.

Cortical Labs develops computational cognitive neuroscience solutions that integrate machine learning and neural engineering to advance brain-computer interfaces and medical AI applications. The company leverages reinforcement learning and neural network technologies to bridge neuroscience research with practical clinical and commercial implementations.

Cottage Health is a not-for-profit healthcare system serving California's Central Coast with a commitment to delivering quality professional healthcare services. The organization operates hospitals and healthcare facilities dedicated to providing comprehensive medical care to its regional communities.

Creative Destruction Lab is a startup support organization that accelerates early-stage companies through mentorship and intensive programs focused on transformative technologies including artificial intelligence, quantum computing, and neurotechnology across sectors such as climate, space, health, and digital society. The Lab's Expert in Residence for Growth Strategy provides strategic guidance to help innovative ventures scale and create meaningful impact through technological breakthroughs.

Cumulus Neuroscience applies machine learning and deep information technology to advance digital health solutions in neuroscience and brain health. The company leverages biotechnology research and life sciences expertise to develop innovative platforms that support clinical and research applications in the neurotech industry.

Deallus provides strategic consulting services to pharmaceutical and life sciences companies, specializing in portfolio strategy, lifecycle management, competitive positioning, and emerging market entry through data-driven analysis and simulation exercises. The firm supports clients in developing comprehensive brand strategies, supply chain optimization, and mature market navigation through tailored strategy workshops and competitive intelligence insights.

Draig Therapeutics is a biotechnology company developing selective receptor modulators targeting GABA and glutamate receptors to address psychiatric disorders and mental health conditions. The company conducts clinical trials and pharmaceutical research focused on creating transformative treatments for neurological and psychiatric indications.

DUSQ is a neurotech wellness company that develops app-connected devices and AI-driven wellness plans designed to enhance mental resilience and physical fitness through evidence-based neuroscience innovation. The platform combines reflective journaling tools, smart device integration, and ergonomic design to deliver personalized wellness experiences that support users' mental and physical health goals.

Eargym is a B Corp that develops research-backed auditory training exercises and digital healthcare solutions designed to improve hearing health and cognitive function through evidence-based auditory neuroscience. The company manufactures medical equipment and supplies while building a hearing data ecosystem that supports wellness and fitness services for cognitive and auditory health.

ECA Medical specializes in the full lifecycle development of spine and orthopedic medical devices, offering comprehensive services from concept through commercialization including injection molding, packaging, and sterilization. The company provides surgery-ready orthopedic kits and disposable instruments designed with patient safety as a core focus.

Elemind Technologies develops non-invasive brain-computer interface technology using EEG-based neuromodulation to treat sleep disorders and regulate sleep cycles. The company's neuroscience platform leverages advanced signal processing and targeted neuromodulation to improve sleep quality and address underlying neurological conditions.

Empatica develops wearable biosensors and software platforms that enable remote monitoring of physiological and neurological conditions, including epilepsy and Parkinson's disease, for both clinical research and real-world patient care. The company's hardware and affective computing technologies capture biometric data to support clinical decision-making and improve patient outcomes through continuous health monitoring.

Emteq Labs develops advanced neurotech solutions that combine sensor fusion, computer vision, and emotional analytics to create innovative wearable devices and immersive experiences in virtual and augmented reality environments. The company's health tech platform leverages biometric sensing and digital health innovation to enable real-time emotional and cognitive insights for applications across consumer wellness, enterprise, and healthcare sectors.

eNeura develops FDA-cleared neuromodulation devices designed to treat migraine attacks, combining smart diary technology with wearable medical technology to provide patients with integrated care solutions. The company's B2C approach delivers healthcare equipment and neurotech innovation directly to consumers seeking evidence-based migraine management and treatment options.

Entropik is a neurotech SaaS platform that uses patented behavioral AI and voice tonality analysis to provide consumer insights and enhance customer experience through advanced UX testing. The company leverages neuroscientific research and development to help organizations understand user behavior and optimize their products based on real emotional and cognitive responses.

Eodyne Systems S.L. is a medical equipment manufacturer specializing in science-based ICT solutions for neurorehabilitation, developing virtual reality and rehabilitation gaming systems designed to improve patient outcomes in post-stroke recovery. The company's digital health technologies aim to enhance quality of life through innovative, technology-driven rehabilitation solutions.

Evasc Neurovascular manufactures innovative medical devices for neurointerventional surgery, specializing in patented flow effect technology for aneurysm occlusion and other neurovascular interventions. The company develops repositionable neurointerventional devices designed to advance minimally invasive treatment options for complex neurological conditions.

Evox Therapeutics Ltd is a biotherapeutics company specializing in exosome-based drug development, leveraging natural nanotechnology for genetic medicine and gene knockdown applications. The company provides research and research services focused on neuroscience applications, utilizing exosomes as a platform for delivering therapeutic interventions.

Flow Neuroscience develops transcranial direct current stimulation (tDCS) medical devices designed to treat depression through non-invasive brain stimulation technology. The company combines neuroscience research with neuromodulation techniques to provide patients and psychiatrists with evidence-based therapeutic solutions for mood disorders.

GENAIZ is a neurotech company specializing in artificial intelligence and intelligent automation solutions for the pharmaceuticals, biotech, and life sciences industries. The company provides software development services supporting contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) to accelerate drug discovery and development processes.

Google DeepMind is an artificial intelligence research laboratory that develops advanced machine learning systems and deep learning models, with particular expertise in reinforcement learning and applications across biological research and systems neuroscience. The organization applies its AI capabilities to address complex challenges in environmental sustainability and energy management while conducting foundational research services in computational intelligence.

Grandir Group is an impact-driven education services company dedicated to early skills development and child well-being through multilingual education programs with a global presence. The organization focuses on combining entrepreneurship with social impact to foster foundational learning and development in children across diverse communities worldwide.

Greenhouse Coaching provides executive coaching and organizational consulting services specializing in career transitions, personal growth, and strategic planning for corporate teams. The firm leverages expertise in values alignment and career change guidance to support individuals and organizations navigating professional development and job search initiatives.

Headversity provides digital resilience training and mental health solutions designed to promote proactive mental health and behavior change in organizational settings. The platform combines health promotion, employee engagement, and consulting services to support workplace health and safety through evidence-based digital mental health training programs.

Heights develops science-backed nutritional supplements formulated for mental performance optimization and daily wellness, utilizing bioavailable nutrients designed to enhance cognitive function and overall health. The company provides wellness and fitness services that leverage evidence-based nutritional science to support health optimization for consumers seeking scientifically validated supplement solutions.

i-BrainTech develops brain-computer interface technology and medical devices designed to enhance human performance through advanced visualization training and neurotechnology solutions. The company specializes in athlete recovery and sports performance optimization, leveraging real-time brain activity monitoring and feedback systems to improve training outcomes.

Iberchem is a chemical manufacturing company specializing in fragrance creation and emotional scent design for a diverse range of consumer products including fine fragrances, body care, air care, home care, and fabric care applications. The company leverages expertise in fragrance formulation to develop distinctive scent solutions that enhance product appeal across multiple market segments.

Immersion is a SaaS platform that leverages consumer neuroscience and neuromarketing technology to measure and optimize experiences within the experience economy. The company provides marketing research and analytics solutions designed to help organizations enhance corporate events and consumer engagement through data-driven insights.

IMNEWRUN is a neurotech company developing innovative biologics and neuroscience platforms designed to cross the blood-brain barrier and treat neurodegenerative diseases through immune checkpoint modulation and neuroinflammation resolution. The company leverages advanced research in brain pharmacokinetics to create therapeutics that address critical unmet needs in neurological disorders.

Innovate BC is a leading innovation and entrepreneurship organization in British Columbia that supports startups and technology companies through accelerator programs, competitions, and venture development initiatives. The organization provides resources, mentorship, and funding opportunities designed to help entrepreneurs launch and scale their ventures across various technology sectors, including emerging neurotech and brain-computer interface innovations.

Insightec is a medical device company specializing in magnetic resonance-guided focused ultrasound (MRgFUS) technology for non-invasive therapeutic treatments across neurological and oncological applications. The company develops outpatient-based ultrasound ablation solutions designed to enhance patient outcomes while reducing procedural invasiveness in healthcare settings.

Insitro is a neurotech company that combines physics, biology, and data science to revolutionize drug discovery and development for neurological diseases including ALS. The company leverages innovative computational approaches and metabolic insights to accelerate the creation of new medicines for patients with currently untreatable conditions.

Jyzen offers integrative wellness and advanced diagnostic services combining neurotechnology and concussion recovery protocols to optimize human performance and antiaging outcomes. The company specializes in personalized wellness solutions leveraging vasper technology and evidence-based interventions for fitness optimization and neurological health management.

Kiin develops immersive neurotech experiences that leverage computer graphics and animation to enhance cognitive training and medical rehabilitation through multisensory engagement. The company's platform supports diverse learning approaches and research applications, with a focus on inclusive design and evidence-based outcomes for cognitive development and therapeutic interventions.

King's College London is a prestigious research institution offering comprehensive education and research services in neurotech and related fields, supporting student development and fostering innovation through its historic academic programs. The college actively engages with startups, venture capital, and social innovation initiatives, leveraging its heritage and resources to support ventures for good and finance-focused research that bridges academic excellence with real-world impact.

Kynexis is a biotechnology company specializing in biomarker-guided therapeutic development for neuropsychiatric and cognitive impairment disorders. The company employs a biomarker-based approach to optimize pharmacokinetics and enable targeted therapy design in clinical trials for neuropsychiatric drugs.

Linus Health develops AI-powered digital health software that enables remote cognitive testing and assessment, leveraging proprietary digital biomarkers including the DCTclock technology to support clinical research and neurological evaluation. The company's platform combines software development with medical device capabilities to deliver scalable, accessible cognitive testing solutions for neurology and digital health innovation.

Lovevery is a subscription toy service that designs neuroscience-based educational toys and early learning tools specifically created to support brain growth and development in toddlers. The company combines developmental research with curated toys, educational resources, and parent support materials to provide a comprehensive early learning experience.

Marlee is an AI-powered coaching platform designed to help founders, entrepreneurs, and leaders optimize their performance and decision-making through personalized guidance and insights. The company specializes in founder due diligence, leadership development, and productivity enhancement to support the future of work in the startup ecosystem.

mBrainTrain develops AI-powered neuroergonomic solutions that leverage mobile EEG technology to optimize human performance and wellbeing across various applications. The company's wearable hardware and mobile device integration enable real-time brain activity monitoring and personalized insights for individual and enterprise users.

Metabolon, Inc. is a metabolomic analysis company that provides comprehensive human metabolome profiling and biomarker discovery services to advance clinical research and drug development. The company specializes in analyzing health data from clinical studies to identify disease biomarkers, support phenotyping efforts, and improve understanding of conditions including diabetes and inherited metabolic disorders.

Milton Education is a digital learning platform specializing in English language education resources, exam preparation materials, and didactic content designed for ESL students and secondary-level learners. The company provides comprehensive digital publishing solutions and educational resources tailored for English language teachers and students across multiple proficiency levels.

Mindstep provides B2B personalized cognitive health solutions that enable remote assessment and risk detection through AI-powered triage technology. The company offers therapy provider tools designed to support mental health professionals and government agencies in delivering scalable, data-driven cognitive care.

mjn-neuro develops advanced neurotech medical devices and AI-powered solutions focused on epilepsy management and neurohealth innovation through big data analytics. The company combines biotechnology research with social impact initiatives to create intelligent diagnostic and therapeutic tools for neurological conditions.

Molecule is a blockchain-based platform that enables researchers and biotech companies to tokenize and fund drug development projects through innovative token bonding curves and decentralized fundraising mechanisms. The company leverages distributed ledger technology to democratize access to intellectual property in pharmaceutical and life sciences research, facilitating novel funding models for health and biotech innovation.

Montara Therapeutics, Inc. is a biotechnology company leveraging UCSF-licensed technology to develop target-specific therapeutic drugs for neurological diseases, including treatments for previously undruggable targets such as KRAS. The company focuses on improving drug safety and efficacy through enhanced therapeutic index design for patients with difficult-to-treat neurological conditions.

Muse® by Interaxon Inc. is a neurotechnology company that develops brain-sensing EEG headbands and biofeedback applications designed to enhance meditation, sleep, and mental wellness through real-time neurofeedback. The company combines wearable brain sensing technology with immersive experiences and user experience design to provide accessible neurotechnology solutions for consumers seeking to optimize cognitive performance and emotional well-being.

Nalu Medical, Inc. manufactures advanced neuromodulation technology for treating neuropathic pain through a rechargeable external device that offers reversible therapy solutions for B2B medical equipment markets. The company's MRI-conditional devices are supported by real-world data and designed to provide innovative pain management alternatives.

Nanion Technologies develops automated patch clamp systems and high-throughput cellular assays for ion channel research, cardiotoxicity screening, and drug discovery in the biotechnology sector. The company specializes in lipid bilayer technology and automated electrophysiology platforms, providing comprehensive solutions for pharmaceutical and biotech researchers worldwide.

NanoDx, Inc. develops point-of-care diagnostic devices for the rapid detection and assessment of traumatic brain injury and concussion using precision medicine approaches. The company's medical device technology enables healthcare providers to deliver timely, accurate diagnoses to support patient outcomes in traumatic brain injury management and mental health applications.

NAOX Technologies develops wearable neurotechnology and home EEG monitoring devices that enable non-invasive measurement and analysis of brain activity for health and wellness applications. The company specializes in medical device manufacturing, combining IoT capabilities with neuroscience expertise to deliver accessible brain monitoring solutions for consumer and clinical use.

Neurelis, Inc. is a biopharmaceutical company specializing in the development and manufacturing of FDA-approved therapies for neurological conditions, particularly epilepsy treatments, utilizing its proprietary drug stabilization and Intravail technology platforms. The company focuses on advancing pharmaceutical manufacturing and drug development to deliver innovative solutions for patients with neurological disorders.

Neuro-Bio Ltd is a biotechnology company specializing in drug discovery and biomarker development for central nervous system disorders and neurodegenerative diseases. The company leverages advanced neurobiology research and biomarker validation techniques to advance therapeutic solutions for neurological conditions.

NeuroBrave develops advanced neurotech software solutions that leverage deep learning and real-time data processing to support neurotechnology research and development, with expertise in wearable device integration and spectral interference removal. The company prioritizes GDPR compliance and offers comprehensive software development services tailored to the neurotech industry's complex data and regulatory requirements.

NeuroEM develops innovative neurotech solutions focused on cognitive and brain health, with particular emphasis on Alzheimer's disease research and treatment through advanced brain protein disaggregation technologies. The company manufactures medical equipment and leverages neuroimaging and biotechnology expertise to advance p-tau biomarker research and therapeutic approaches.

Neurogram™ is a neurotech company specializing in neuroscientific research services and medical device integration, offering scalable neurodiagnostic solutions for healthcare and research applications. The company provides deeptech infrastructure and digital signature capabilities designed to advance diagnostic laboratory efficiency and clinical neuroscience workflows.

NeuroSpring develops innovative neurotech solutions that combine neuroscience, artificial intelligence, and medical device technologies to advance treatment options in neurology and emergency medicine. The company's research and development efforts focus on creating next-generation pharmaceutical and medical device therapies that address critical neurological conditions.

Neurosteer develops advanced neurotech solutions for monitoring and analyzing brain activity, specializing in digital health applications for neurological and neurodegenerative disorders. The company manufactures electromedical equipment designed to decompose and measure brain activity patterns for clinical and navigational applications.

Neurotech Pharmaceuticals, Inc. is a biotechnology company specializing in ocular gene therapy and retinal regeneration treatments, developing innovative biologic drug implants for long-term therapeutic solutions. The company conducts biotech clinical trials focused on retinal therapy and advanced ocular therapeutics to address vision-related diseases.

NextSense, Inc develops advanced ear-EEG wearable technology and AI/ML-powered software platforms that enable real-time brain health monitoring through innovative hearable devices. The company's data platform processes neural signals to deliver actionable insights for sleep optimization and comprehensive brain wellness management.

NMA (Neuromonitoring Associates) provides intraoperative neuromonitoring (IONM) and surgical nerve monitoring solutions to hospitals and healthcare facilities, utilizing their AMP platform to enhance neurosurgical procedure safety and improve patient outcomes. The company delivers B2B patient safety technology designed to protect neural structures during surgery and align clinical excellence with patient care standards.

NordicNeuroLab specializes in advanced neuroimaging solutions, providing MRI-compatible hardware and software designed for functional MRI (fMRI) research and clinical applications. The company offers innovative paradigm design tools, MR-compatible monitoring systems, and specialized fMRI hardware to support cutting-edge brain imaging studies and ASL imaging protocols.

North AI provides AI-powered video content analysis and audience engagement insights services, leveraging advanced artificial intelligence to deliver user-friendly analytics and heat map visualizations. The company's platform enables content creators and businesses to understand viewer behavior and optimize engagement through intuitive, data-driven tools.

Northwestern University is a leading research institution offering comprehensive programs across materials science, medicine, arts and sciences, communications, and journalism, with significant applications in advancing neurotechnology and brain-related research. The university supports neurotech innovation through interdisciplinary collaboration, entrepreneurship initiatives, and its robust engineering and medical research facilities.

Novus Biologicals, a Bio-Techne brand, provides research-grade antibodies, lysates, kits, peptides, and custom protein services for neuroscience and life science research. The company specializes in biochemistry reagents including secondary antibodies, IHC microarrays, and cancer research products designed to support academic and pharmaceutical research applications.

NRG Therapeutics is a biotechnology company developing first-in-class, orally bioavailable mitochondrial inhibitors designed to trigger mitochondrial DNA release and activate the cGAS/STING pathway for treating neurodegenerative diseases. The company's therapeutic approach targets pathogenic protein-related conditions, including ALS, through novel mechanisms rooted in neuroscience and mitochondrial biology research.

Nudge develops scalable brain interface technology using high-resolution ultrasound transducer arrays and phased array systems to enable precise brain circuit targeting for neuroscience research and biotechnology applications. The company's ultrasound-based approach provides a non-invasive method for neural stimulation and mapping, supporting advanced brain interface innovation across research and therapeutic domains.

NYU Langone Health is a world-class medical center that provides comprehensive patient care, conducts cutting-edge biomedical research, and offers premier medical education across multiple specialties including neurology, cardiology, oncology, and orthopedics. The health system integrates clinical excellence with research innovation to advance treatment options in neurology, vascular surgery, rheumatology, rehabilitation, and children's health services.

Oscillo Biosciences develops AI-powered digital therapeutics that leverage advanced signal processing and neuroscience to optimize neural synchrony and therapeutic outcomes. The company combines artificial intelligence with biotechnology to deliver clear, eloquent solutions for neurological conditions through innovative neurotech applications.

Osmo develops innovative neurotechnology solutions that bridge the gap between digital and physical play experiences for children and educational institutions. The company's platform combines AI-powered software with tangible gaming elements to enhance cognitive development while maintaining a focus on sustainability and accessibility across consumer, healthcare, and educational markets.

Override is a virtual healthcare platform that delivers personalized pain management coaching and behavioral health support for chronic pain patients. The company integrates evidence-based physical therapy and pain medicine guidance through digital therapeutics to help hospitals and health systems enhance their pain management capabilities.

Pangea Bio is a biotechnology company leveraging AI-powered drug discovery to develop next-generation CNS pharmaceuticals, with capabilities spanning from research through regulatory submission and clinical trials. The company combines advanced computational approaches with deep pharmacology expertise to accelerate the development of novel neurological therapeutics.

Parker University is an accredited institution offering diverse healthcare and technology programs including degrees in health information management, chiropractic medicine, radiologic technology, and computer information systems. The university provides educational pathways ranging from certificates and associate degrees to bachelor's and master's level qualifications in health sciences and business management.

Parkview Health is a comprehensive health system providing hospital and healthcare services across multiple facilities with a focus on patient safety, experience, and community outreach initiatives. The organization prioritizes healthcare research and system leadership to advance patient care quality and safety standards throughout its network.

Penn Medicine is a leading academic medical center affiliated with the University of Pennsylvania that provides comprehensive healthcare services across multiple specialties including neurology, neurosurgery, oncology, and transplantation. The health system combines clinical excellence with research and education, serving patients through its network of hospitals and specialized programs in women's health, orthopedics, otorhinolaryngology, and general surgery.

Phagenesis develops innovative neurostimulation technology for the treatment of dysphagia, a swallowing disorder affecting stroke survivors and other patient populations. The company's solutions combine neuroscience expertise with clinical applications in stroke rehabilitation and speech-language pathology to improve patient outcomes.

PLUX Biosignals is a biomedical engineering company specializing in wireless biosignal acquisition, processing, and analysis technologies for medical devices and research applications. The company provides innovative biosignal solutions, educational platforms, and biofeedback systems designed to advance biosignal development and clinical innovation.

Predictheon develops AI-powered predictive monitoring solutions that use mathematical modeling and machine learning to optimize perioperative blood management and track cognitive function during general anesthesia. The company's data analysis platform enables real-time detection of adverse events and supports clinical decision-making in surgical settings.

Presidio Medical, Inc. manufactures ultra-low frequency (ULF) neuromodulation medical devices designed to provide minimally invasive pain relief solutions through advanced circuit design and innovative product development. The company specializes in medical equipment and supplies manufacturing, offering therapeutic services and solutions backed by expertise in precision medicine and digital health integration.

Prisma Health is an integrated healthcare system providing comprehensive medical services across hospitals, clinics, and community health centers with a focus on clinical research and medical training. The organization is committed to healthcare innovation and improving access to care for chronic disease management and underserved populations.

PsychoGenics provides integrated neuroscience research services utilizing advanced analytical techniques including EEG, electrophysiology, microdialysis, and histology/immunohistochemistry to support drug discovery and development. The company specializes in preclinical evaluation through comprehensive animal models, behavioral testing, and bioanalysis with rigorous quality assurance standards.

RapidPulse, Inc. manufactures neurointerventional devices designed to address the first pass effect in aspiration thrombectomy procedures for acute ischemic stroke treatment. The company conducts stroke clinical studies and first-in-human experiences to advance innovative medical equipment solutions in the neurointerventional healthcare sector.

Rebion develops advanced medical devices and optical technologies designed to improve neural performance and vision screening, with specialized solutions for treating conditions including amblyopia, strabismus, and traumatic brain injury (TBI). The company manufactures innovative neurotech equipment that integrates optics and neural assessment capabilities to enhance patient outcomes in vision and neurological health.

Reveri develops neurotechnology solutions that leverage hypnosis and guided imagery to address sleep disorders, anxiety, pain, and overall wellness through a digital platform. The company's technology applies neuroscience-based approaches to help users improve brain health and manage conditions non-pharmacologically through their innovative health tech application.

Rhythmlink International, LLC specializes in the design and manufacturing of neurotech medical devices, including electrodes and specialized equipment for neurological monitoring and research applications. The company offers comprehensive services spanning custom product design, contract manufacturing, private labeling, and custom packaging to meet the specific needs of healthcare and research organizations.

RWJBarnabas Health is a comprehensive healthcare system providing hospital services, primary care, pediatric care, and mental health treatment across multiple locations. The organization conducts clinical trials, offers health education programs, and specializes in managing complex health conditions through both traditional healthcare delivery and ambulatory ventures.

Samphire Neuroscience develops neurotechnology wearables and accessories designed to address women's health conditions including premenstrual dysphoric disorder, menstrual migraine, premenstrual syndrome, and dysmenorrhea. The company's innovative approach combines neurotech solutions with women's wellness to provide targeted support for menstrual-related symptoms.

Seedtag is an advertising technology company specializing in contextual and neurocontextual targeting solutions that deliver native and in-image advertising across digital platforms. The company's VP, Brand Partnerships leads relationships with brands seeking to optimize ad placement through advanced contextual intelligence and consumer internet applications.

Seneca Learning is an educational technology company that applies neuroscience and cognitive science principles to develop learning software designed for students and educational institutions. The company offers SaaS-based enterprise solutions that leverage psychological research to optimize knowledge retention and academic performance.

Sensars develops advanced neural interface technology and closed-loop nerve stimulation systems that integrate sensor arrays for real-time monitoring and therapeutic intervention. The company manufactures medical equipment leveraging European Horizon funding support to advance clinical applications of its proprietary sensor technology and neural stimulation platform.

SetPoint Medical develops bioelectronic medicines that leverage vagus nerve stimulation to treat inflammatory and autoimmune diseases, including rheumatoid arthritis, through proprietary neuromodulation technology. The company designs and manufactures advanced medical equipment that targets the body's neural circuitry to modulate immune responses and reduce chronic inflammation.

Sevaro provides virtual neurointensive care and teleneurology services, offering remote EEG reading, virtual acute stroke services, and virtual neurohospitalist services to improve patient outcomes across acute and post-acute care settings. The company's medical technology platform enables hospitals and healthcare systems to access specialized neurological expertise and coordination remotely, enhancing care delivery and reducing geographic barriers to neurocritical care.

Sharper Sense is a neurotech startup specializing in the development and manufacturing of noninvasive neurostimulation patches designed to enhance sensory performance and cognitive function in humans. The company focuses on innovative brain stimulation solutions tailored for athletic performance and other applications requiring heightened neurological optimization.

Smartlens, Inc. develops advanced eye pressure monitoring technology for remote patient monitoring and personalized glaucoma management, utilizing AI-driven insights to enable home-based IOP (intraocular pressure) testing and optometry care. The company's innovative solutions support clinicians in delivering tailored treatment plans while expanding access to continuous eye health monitoring outside traditional clinical settings.

Soihtu DTx develops game-based digital therapeutics that leverage neuroscience principles to deliver evidence-based mental health interventions through engaging video game experiences. The company offers direct-to-consumer and B2C services designed with user-centric approaches to make mental health treatment accessible and effective.

Space Applications Services NV/SA develops advanced software solutions and control systems for space applications, including mission control centres, earth observation systems, and human-machine interfaces for robotics and virtual environments. The company specializes in wearable computing technologies and data centre solutions, with expertise in supporting the ICE Cubes Service for orbital payload operations.

Spark Biomedical Inc is a medical device company specializing in neuromodulation and bioelectronic medicine technologies designed to address neurological health conditions. The company develops and manufactures innovative neuromodulation devices that leverage advances in neuroscience and biotechnology to provide therapeutic solutions for patients.

SPARK Neuro develops AI-powered neurotech solutions that measure and analyze biometric data from the central nervous system to identify biomarkers for advertising effectiveness, consumer behavior, and neurological diseases including Alzheimer's. The company applies advanced neuroscience research and machine learning to bridge neuromarketing insights with medical technology applications.

SpecialtyCare provides intraoperative neuromonitoring (IONM) and operating room support services, including EEG monitoring, perfusion management, and remote neuromonitoring capabilities for minimally invasive surgical procedures. The company offers specialized expertise in ECMO support and sterile processing department services to enhance patient safety and surgical outcomes.

STALICLA is a neurotech company specializing in novel drug delivery systems (NDDS) and big data analytics focused on advancing treatment options for neurodevelopmental disorders, including autism spectrum disorder (ASD). The company combines innovative research methodologies with financing solutions to accelerate the development of therapeutic interventions for neurological conditions.

Stratus provides cloud-based EEG software solutions that leverage AI-driven analysis to enable remote review and interpretation of neurodiagnostic data for hospitals and healthcare facilities. The company's platform supports medical and diagnostic laboratories in streamlining EEG analysis and research and development through accessible, cloud-based technology.

Sunnybrook is a leading academic health sciences center that leverages neurotech and digital health innovations to advance patient care across neurology, oncology, maternal health, and specialized populations including elderly and burn patients. The organization integrates cutting-edge technology with clinical expertise to improve outcomes for diverse patient groups ranging from newborns to those managing chronic conditions like arthritis.

Sutter Health is a not-for-profit integrated health care system providing comprehensive clinical services across Northern California through hospitals, physician offices, and community-based care facilities. The organization serves seniors and diverse patient populations through digital health solutions and coordinated care delivery designed to improve health outcomes and access to quality healthcare services.

Sygnature Discovery is a drug discovery company specializing in computational chemistry, medicinal chemistry, and physical sciences to accelerate the development of novel therapeutics. The company offers integrated services including protein crystallography, DMPK analysis, in vitro bioscience, drug formulation, and synthetic chemistry to support pharmaceutical and biotech clients throughout the drug discovery process.

SynapCell develops integrated electrophysiology platforms and predictive biomarkers for epilepsy and mesial temporal lobe epilepsy (MTLE) research and drug development. The company's technology combines pharmacoEEG, auditory event-related potentials (aERP), and neural network analysis to enable early detection and patient stratification in neurological disorders.

Synchron develops minimally invasive brain-computer interface technology that enables direct communication between the human brain and external devices through advanced signal processing and machine learning algorithms. The company's neuroprosthetic platform leverages neuromodulation techniques to restore function and independence for individuals with neurological conditions and paralysis.

Tallahassee Memorial HealthCare is a comprehensive healthcare system providing specialized services across urgent care, orthopedics, critical care, cardiovascular medicine, neuroscience, trauma, and pediatric care. The organization serves the Tallahassee region with integrated medical services including women's and maternal health, leveraging clinical expertise across multiple specialty disciplines.

Technophage, SA is a neurotech company specializing in preclinical development and clinical trials for neuroscience applications, utilizing innovative zebrafish screening platforms for drug candidate identification and validation. The company provides comprehensive support across regulatory affairs, project management, and infection-related research, leveraging small domain antibodies as a core technology platform.

The Happiness Index is an HR technology platform that leverages pulse survey technology and positive psychology principles to measure and improve employee well-being and organizational culture. The company provides data-driven insights to HR teams and organizations seeking to enhance workplace engagement, mental health, and overall employee experience through continuous feedback mechanisms.

Theranica is a neurotech company specializing in digital therapeutics for migraine management, best known for its FDA-cleared Nerivia wearable device that uses remote electrical neuromodulation to treat migraines. The company develops innovative medical equipment combining digital health technology with wearable devices to provide patients with non-invasive migraine relief solutions.

Time is Brain develops portable medical devices that utilize N20 signals to assist in acute ischemic stroke (AIS) diagnosis and prognosis, enabling rapid assessment to support clinical decision-making for mechanical thrombectomy and other stroke interventions. The company's Brain20 technology platform delivers real-time neurodiagnostic capabilities at the point of care, facilitating faster stroke evaluation and treatment protocols.

UHN Foundation is a non-profit organization dedicated to fundraising and supporting medical research initiatives at University Health Network, with a specific focus on advancing arthritis research and surgical innovations. The foundation works to enhance patient care and services by funding critical research programs that address significant health challenges.

The University of Washington is a leading public research institution that conducts groundbreaking faculty research across multiple disciplines, including environmental sustainability and climate change studies, while fostering technology transfer and innovation. The university is committed to higher education accessibility and diversity initiatives, leveraging its public mission to advance neurotech and related fields through collaborative research and community engagement programs.

Unlearn.AI applies machine learning and deep learning techniques to optimize clinical trials and accelerate drug development through advanced computational biology and biostatistics. The company leverages artificial intelligence and data science to help pharmaceutical organizations design more efficient trials and extract greater insights from clinical data.

Unmind is a digital mental health platform that combines neuroscience-based insights with workplace wellness solutions to support employee mental health and wellbeing. The company provides proactive mental health tools and interventions designed to enhance employee engagement and foster a culture of psychological safety within organizations.

Valencia Technologies develops electroceutical neuromodulation devices designed to treat intractable pain and urinary incontinence through innovative medical technology. The company leverages crowdfunding and direct-to-consumer approaches to advance its neurotech solutions for urological and pain management applications.

Valkyrie Industries develops advanced haptic and force feedback technologies that enable immersive human-computer interaction across virtual, augmented, and mixed reality environments. The company specializes in wearable teleoperation systems that deliver tactile feedback, allowing users to experience realistic sensory responses in remote operation and extended reality applications.

ViewMind Inc. develops non-invasive brain assessment software that measures cognitive function and drug impact through proprietary neurocognitive testing technology. The company's platform supports neurodegenerative disease monitoring, clinical trial operations, and cognitive domain analysis across brain regions for improved disease management and therapeutic evaluation.

VINHOOD is a digital platform that simplifies wine discovery and purchasing through an omnichannel experience, combining personal communication and consumer-focused technology to enhance how customers explore and buy wine online. The company leverages digital innovation to streamline the wine selection process and improve the overall customer experience across multiple touchpoints.

Wisear develops neural control technology that enables touchless, gesture-based interaction with devices through advanced brain-computer interfaces designed for consumer electronics, gaming, and safety-critical applications. The company's neurotech solutions support metaverse integration and neural control systems that enhance human-computer interaction across computing and electronics manufacturing sectors.

Zeto develops rapid full-montage EEG technology designed to streamline neurological diagnostics and seizure detection through innovative medical devices. The company leverages cloud-based solutions to enhance healthcare delivery and support medical equipment manufacturing in the neurology sector.

Zoundream develops non-invasive infant monitoring software that leverages deep learning and sound recognition technology to analyze baby sounds and provide real-time health insights to parents and caregivers. The company combines machine learning algorithms with accessible software solutions to transform acoustic data into actionable information for early detection of health issues in infants.

AgenT is a biotechnology company leveraging artificial intelligence and machine learning to develop innovative diagnostic tools and preventive treatments for Alzheimer's disease. The company combines cutting-edge neurotechnology with biotechnology research to advance early detection and intervention strategies in neurodegenerative disease management.

Bulbitech AS develops advanced neurotech solutions specializing in eye tracking and nystagmography technologies for neurological and ophthalmological diagnostics. The company delivers teleophthalmology and telemedicine platforms that enable remote optometric and neurological assessments through innovative eHealth capabilities.

Constant Therapy is a digital therapeutics platform that provides personalized, evidence-based therapy exercises for stroke recovery, traumatic brain injury rehabilitation, and learning disorders through speech, occupational, and speech pathology interventions. The company's medical case management system integrates digital therapy delivery with clinical oversight to support patient outcomes across cognitive and motor rehabilitation.

Equa Health develops neuroscience-based digital health solutions that combine mindfulness training and emotional regulation techniques through app-based interventions designed to support wellness and fitness services. The company offers evidence-backed mindfulness curriculum and emotional regulation tools for health practitioners seeking to integrate behavioral wellness support into their practice.

Flowly is a neurotech company that leverages virtual reality, artificial intelligence, and storytelling to create immersive healthcare experiences and medical applications. The company integrates advanced technology with big data analytics to develop innovative solutions for the healthcare and medical industries.

Kandu develops brain-computer interface (BCI) and EEG-based robotic rehabilitation systems designed to aid stroke and cerebrovascular accident (CVA) recovery through neurotechnology. The company's platform combines neuroscience with robotics to deliver personalized motor rehabilitation and neurorehabilitation solutions for patients requiring post-stroke therapy.

MAG4Health develops advanced magnetoencephalography (MEG) medical devices utilizing helium-4 metastable state technology to provide high spatial and temporal resolution functional brain imaging for clinical and research applications. The company manufactures cutting-edge neurotech equipment designed to serve healthcare institutions and government agencies requiring high dynamic range neuroimaging capabilities.

Medicortex Finland Oyj is a biotechnology company specializing in diagnostic solutions for traumatic brain injury (TBI) and concussions in high-risk populations including professional athletes, soldiers, and combat personnel. The company develops advanced neurotech diagnostics to enable rapid and accurate identification of brain trauma and support clinical decision-making in acute care settings.

Mindstate Design Labs is a neurotech company specializing in the research and development of therapeutic psychedelic compounds through advanced neurobiological mapping and drug development. The company leverages neuroengineering, consciousness state engineering, and neuroscience data analysis to advance biotechnology solutions in the therapeutic psychedelics space.

Mindway AI develops artificial intelligence and behavioral machine learning software designed to identify and prevent problem gambling through real-time player protection systems. The company's responsible gambling platform uses virtual expert technology to detect at-risk gambling behaviors and support safer gaming environments across the industry.

Motion Informatics Ltd develops AR-guided neurorehabilitation software and medical equipment that combines gamified therapy with predictive analytics to enable remote motor re-education and recovery for patients in hospital and healthcare settings. The company's patient-centric platform delivers personalized, engaging therapeutic exercises designed to optimize neuromotor outcomes through innovative technology and data-driven insights.

PrecisionLife leverages advanced genomic analysis and data analytics to accelerate drug discovery and identify novel therapeutic targets for chronic diseases. The company specializes in clinical research and diagnostic solutions that integrate cutting-edge biology to advance precision medicine development.

SciNeuro Pharmaceuticals is a biotechnology research company specializing in proteinopathy and neuroinflammation, leveraging biomarker-driven research approaches to advance therapeutic development. The company focuses on research and development across physical, engineering, and life sciences disciplines to address neurodegenerative diseases.

SOMAREALITY develops virtual reality applications and software solutions designed to advance medical and healthcare outcomes through immersive technology. The company specializes in medtech VR apps, data analytics, and IT consulting services that integrate human factors engineering to create unified digital health experiences.

SynchNeuro, Inc. develops advanced neurotech solutions that combine EEG data collection through discreet behind-the-ear sensors with machine learning algorithms to enable personalized health management and continuous monitoring of critical health metrics. The company leverages biotechnology research and digital health innovations to provide real-time health tracking and data analysis for individualized wellness optimization.

Syndeio Biosciences is a biotechnology company developing a synapse pharmacology platform designed to identify and advance rapid-acting therapies for neurodegenerative diseases through precision neuroscience approaches including NMDA receptor modulation. The company leverages behavioral models and EEG analysis to accelerate drug discovery and enable targeted treatments for neurological disorders.

Vistim Labs is a neurotech startup developing diagnostic and monitoring solutions for neurological disorders, with a focus on assessing treatment efficacy and improving patient outcomes in conditions such as Alzheimer's disease and neurodegeneration. The company leverages technology transfer and scientific innovation to advance the clinical understanding and management of progressive neurological conditions.

Wesper develops flexible electronic wearables and machine learning algorithms to monitor sleep and respiratory health for personalized wellness and sleep disorder management. The company's medical-grade devices enable remote patient monitoring and data analytics for outpatient care centers and individual users seeking improved sleep and respiratory health insights.

Abbott's neuromodulation division offers spinal cord stimulation, deep brain stimulation, and dorsal root ganglion therapies through products like the Proclaim DRG Neurostimulator and Infinity DBS system. Their BurstDR stimulation technology has been clinically shown to provide superior chronic pain relief compared to traditional tonic stimulation.

Acadia Pharmaceuticals is a biopharmaceutical company commercializing Nuplazid (pimavanserin), the first FDA-approved drug specifically for hallucinations and delusions associated with Parkinson's disease psychosis. They are also developing treatments for Alzheimer's disease psychosis and Rett syndrome.

Acer Therapeutics is a specialty pharmaceutical company focused on rare neurological and metabolic diseases, developing EDSIVOTM (sodium phenylbutyrate) for urea cycle disorders and other CNS conditions.

Praxis Precision Medicine is developing genetically targeted therapies for epilepsy and essential tremor, including PRAX-628 and PRAX-944, precision ion channel modulators matched to specific genetic variants.

Aleva Neurotherapeutics is a Swiss medical device company developing directional deep brain stimulation leads for Parkinson's disease and other movement disorders. Their directSTIM technology enables highly targeted stimulation to maximize therapeutic benefit while minimizing side effects.

Canadian clinical-stage drug development company repurposing DMT as a stroke recovery treatment and exploring psychedelic compounds for neurological indications. Their AP-188 program targets neuroplasticity following ischemic stroke.

Alto Neuroscience uses EEG-based biomarkers and AI to match patients with psychiatric treatments most likely to work for their unique neurobiology, tackling the trial-and-error problem in antidepressant prescribing. Their precision psychiatry platform has demonstrated the ability to predict antidepressant response before treatment begins using neural signatures.

Canadian psychedelic company developing psilocybin microdosing protocols and digital therapeutics platforms to support mental health and cognitive performance. Their integrated approach combines pharmacology with behavioral health monitoring.

atai Life Sciences is a publicly listed biotech platform company building a portfolio of clinical-stage mental health companies developing psychedelic and non-psychedelic treatments for depression, PTSD, anxiety, and addiction. Their subsidiaries include programs using psilocybin, DMT, MDMA, and novel compounds.

Digital therapeutics company developing VR-enhanced psychedelic integration tools that support the therapeutic process before and after psychedelic medicine sessions. Their immersive environments are designed to maximize neuroplasticity windows post-treatment.

UK and European psychedelic medicine company developing ketamine-assisted psychotherapy treatments for addiction, particularly alcohol use disorder. They operate clinics and conduct Phase II/III clinical trials across Europe.

Awakn Life Sciences is a biotech company researching and developing ketamine and MDMA-based treatments for addiction disorders including alcohol use disorder, with clinical operations at their own therapy clinics in the UK. Their AWAKN-002 ketamine-assisted therapy program has completed Phase 2 clinical data for alcohol addiction.

Axsome Therapeutics is a commercial-stage biopharmaceutical company developing novel therapies for CNS disorders, with FDA-approved products including Auvelity for major depressive disorder and Sunosi for excessive daytime sleepiness. Their pipeline spans depression, Alzheimer's agitation, migraine, and narcolepsy.

Battelle's neurotechnology division pioneered NeuroLife, the first BCI system to reconnect a paralyzed person's brain to their muscles to restore hand movement using neural bypass technology. They continue to develop implantable and non-invasive BCI solutions under government and private research contracts.

Beacon Biosignals applies machine learning to EEG data to deliver scalable neural biomarkers for clinical trials and neurology applications. Their Dreem headband and cloud analytics platform help pharma companies measure brain activity endpoints at scale.

UK-based scientific research foundation pioneering psychedelic science and drug policy reform since 1998, collaborating with leading universities on psilocybin, LSD, and cannabis research. They bridge academic research with policy advocacy globally.

Beckley Psytech is a UK-based clinical-stage company developing short-duration psychedelic therapies, with a lead program using intranasal psilocybin (BPL-003) for treatment-resistant depression intended to reduce session time versus oral formulations. They are part of the Beckley Foundation's broader mission to advance psychedelic science.

Clinical-stage biotech developing subcutaneous ketamine formulations and wearable delivery devices for psychiatric treatment outside traditional clinic settings. Their approach aims to make ketamine therapy more accessible and scalable.

Big Health creates prescription digital therapeutics for mental health, including Sleepio for insomnia and Daylight for anxiety, both backed by clinical evidence. Their products are available through employer benefits and health plan coverage.

BioElectronics Corp manufactures wearable, disposable electroceutical patches using pulsed shortwave therapy to treat chronic and post-surgical pain without systemic drug side effects.

Argentinian psychedelic biotech company developing ayahuasca-derived DMT compounds and neural restoration therapies targeting addiction and neurodegenerative conditions. They leverage Latin America's rich ethnobotanical heritage in their drug discovery pipeline.

Bioness develops implantable and external neurostimulation devices for the rehabilitation of patients with neurological conditions such as stroke, multiple sclerosis, and traumatic brain injury. Their StimRouter peripheral nerve stimulator and NESS L300 foot drop system help patients restore functional movement and manage chronic pain.

BioXcel Therapeutics is developing BXCL501, a sublingual film formulation of dexmedetomidine for acute agitation in bipolar disorder and schizophrenia, leveraging AI-driven drug repurposing.

Blackfynn built a cloud-based data management and analytics platform for neuroscience research, enabling teams to store, process, and visualize large-scale neural datasets. The company was acquired by the University of Pennsylvania and spun into the SPARC Data and Connectivity platform.

Boston Scientific's neuromodulation portfolio spans spinal cord stimulation, deep brain stimulation, and sacral neuromodulation for pain, movement disorders, and pelvic conditions. Their Vercise Genus DBS system and WaveWriter Alpha SCS platform represent the company's latest advances in closed-loop, personalized neural therapy.

BrainTrain develops computerized cognitive rehabilitation and neurofeedback software used by neuropsychologists and rehabilitation specialists worldwide. Their Captain's Log and SmartMind systems address attention, memory, and executive function deficits.

BrainBit is an AI-driven neurotechnology company headquartered in California, USA, developing advanced EEG, EMG, and ECG hardware, software, SDKs, and white-label solutions for neurofeedback providers, researchers, wellness organizations, developers, and neurotechnology innovators worldwide. The company offers a comprehensive ecosystem of wearable biosensing devices, professional neurofeedback platforms, developer tools, and integrated software solutions designed for neuroscience research, cognitive performance, education, BCI applications, and wellness programs. BrainBit's innovation strategy is centered on Neurofeedback 2.0 — an AI-powered platform combining multimodal biosignal analysis, biomarker-driven assessment, adaptive neurofeedback protocols, and graph-based knowledge systems to deliver personalized brain training experiences.

BrainCare is a UK medtech company developing a non-invasive wearable device for continuous intracranial pressure monitoring using photoplethysmography signals. Their technology targets brain injury management and neurological monitoring in clinical settings.

BrainCo develops EEG-based brain-computer interface technology for prosthetics, education, and performance optimization, with their Focus edu device used in classrooms to monitor student attention. Their BrainRobotics prosthetic hand uses neural signals to enable intuitive motor control for amputees.

Neurolief is an Israeli medical device company developing the Relivion system, a multi-channel non-invasive transcranial and extracranial neurostimulation device for acute migraine treatment and prevention.

BrainsWay develops Deep TMS (dTMS) systems using patented H-Coil technology that stimulates deeper and broader brain regions than conventional TMS, with FDA clearances for major depression, OCD, and smoking cessation. Their non-invasive devices are deployed in psychiatric clinics across dozens of countries.

Bright Minds Biosciences designs next-generation serotonergic compounds targeting specific 5-HT receptor subtypes to treat epilepsy, PTSD, and addiction with reduced side effects. Their platform leverages computational drug design to create highly selective psychedelic-inspired molecules.

Brightside Health is a virtual mental health platform that combines therapy, psychiatry, and crisis support to treat depression and anxiety with clinically validated outcomes. Their proprietary Brightside Precision Treatment methodology adapts care to each patient's specific symptom profile and history.

Cambridge Cognition is a UK-based company providing digital cognitive assessment tools (CANTAB) used in clinical trials and brain health research worldwide. Their validated neuropsychological tests are trusted by pharmaceutical companies and academic institutions.

Emerging psychedelic biotech developing novel ibogaine-derived compounds for addiction treatment and neurological repair without the cardiac risks of ibogaine itself. Their pipeline targets opioid use disorder and traumatic brain injury.

Cerebral is a digital mental health company offering online access to licensed therapists, psychiatric prescribers, and care counselors for conditions including depression, anxiety, ADHD, and insomnia. Their subscription-based telehealth model has served millions of patients across the United States.

Athira Pharma is a clinical-stage biopharmaceutical company developing ATH-1017, a small molecule hepatocyte growth factor pathway activator aimed at restoring neuronal health in Alzheimer's disease.

Tonix Pharmaceuticals is a CNS-focused biopharmaceutical company developing Tonmya (TNX-102 SL), a sublingual cyclobenzaprine formulation for fibromyalgia and post-traumatic stress disorder.

Cerevel Therapeutics was a clinical-stage neuroscience company developing selective receptor-targeted therapies for schizophrenia, Parkinson's disease, and epilepsy, best known for emraclidine, a muscarinic receptor agonist for schizophrenia. Cerevel was acquired by AbbVie in 2024 for approximately $8.7 billion.

Ceribell has developed a rapid-deployment EEG system with an AI-powered brain seizure monitor for detecting non-convulsive seizures in ICU and emergency settings. Their point-of-care Clarity EEG system enables nurses to apply and interpret EEG results within minutes without a neurologist at the bedside.

Clinical-stage company developing psilocybin-based treatments for obsessive-compulsive disorder, eating disorders, and other hard-to-treat psychiatric conditions. They focus on indication-specific treatment protocols backed by rigorous clinical evidence.

Clerkenwell Health is a UK-based clinical research organization specializing in psychedelic medicine trials, offering full-service CRO capabilities for sponsors conducting psychedelic-assisted therapy studies. They operate dedicated trial sites across the UK.

UK-based psychedelic drug development company advancing novel ketamine and esketamine analogs for treatment-resistant depression and other psychiatric conditions. They focus on improving upon existing approved psychedelic medicines with next-generation compounds.

Cognition Therapeutics is developing CT1812, a small molecule sigma-2 receptor complex antagonist designed to displace toxic amyloid beta oligomers from synapses to treat Alzheimer's disease and dementia with Lewy bodies.

Cognito Therapeutics is developing non-invasive sensory stimulation therapies using 40Hz gamma frequency light and sound to target the neurological mechanisms underlying Alzheimer's disease. Their OVERTURE Phase 3 clinical trial is evaluating the Cognito Therapy System for slowing cognitive and functional decline in mild-to-moderate Alzheimer's patients.

Cogstate develops computerized cognitive assessments used in clinical trials for Alzheimer's disease, sports concussion, and neurological disorders. Their tests are scientifically validated and integrated into major pharmaceutical research programs globally.

Compumedics is an Australian publicly listed company that designs and manufactures sleep diagnostic and monitoring systems, EEG equipment, and transcranial Doppler ultrasound devices for clinical and research use. Their Grael and Somté product families are widely deployed in hospital sleep labs worldwide.

CorTec designs fully implantable neural interfaces and electrode arrays for both research and clinical applications. Their systems support long-term chronic recording and stimulation in freely moving subjects.

Cortivision is developing a non-invasive visual cortex stimulation device for the restoration of partial vision in people with visual impairment due to retinal and optic nerve disease. Their TMS-based neuromodulation approach targets the visual cortex to augment remaining visual function.

Cybin is a clinical-stage biopharmaceutical company developing proprietary psychedelic-based therapeutics, with lead programs targeting major depressive disorder using deuterated psilocybin analogs engineered for improved pharmacokinetics. Their CYB003 and CYB004 molecules are designed to provide more predictable and shorter therapeutic sessions.

Drug discovery company developing non-hallucinogenic psychoplastogenic compounds that promote neural plasticity similar to psychedelics without the perceptual effects. Their TrkB-targeting molecules aim to treat depression, addiction, and neurological disorders.

Dreem developed a consumer-grade EEG headband and companion app that monitors sleep stages in real time and uses bone-conduction audio stimulation to enhance deep sleep quality through neurofeedback. After being acquired by Beacon Biosignals, the Dreem technology continues to power sleep research platforms.

EEG Info, led by neurofeedback pioneer Siegfried Othmer, provides neurofeedback training systems, clinician education, and clinical protocols for treating ADHD, anxiety, PTSD, and brain injury. Their Othmer Method is among the most widely trained neurofeedback approaches globally.

Israeli biotechnology company developing novel psychedelic-inspired compounds derived from tryptamine chemistry for treatment-resistant depression and PTSD. They leverage Israel's strong neuropharmacology research infrastructure to advance their pipeline.

electroCore is a publicly traded bioelectronic medicine company focused on non-invasive vagus nerve stimulation (nVNS). Their gammaCore device is FDA-cleared for cluster headache and migraine prevention and has applications across neurology and inflammation.

Elemind has developed a closed-loop neurostimulation wearable that reads EEG signals in real time and delivers targeted acoustic stimulation to modulate brain states for sleep and focus. Their consumer-grade headband uses proprietary algorithms to synchronize stimulation with individual brainwave patterns.

Eleusis is a life sciences company developing psychedelic-based medicines, with a focus on LSD microdosing for Alzheimer's disease neuroinflammation and psilocybin for major depression. They combine neuroscience research with drug development.

Australian clinical-stage biopharmaceutical company developing MDMA, psilocybin, and cannabis-derived therapeutics for mental health conditions with a data-driven clinical trial platform. They operate licensed clinics to generate real-world evidence for regulatory submissions.

Enspire Medical is developing an implantable sacral neuromodulation device for overactive bladder and bowel dysfunction, featuring wireless recharging and Bluetooth-enabled patient control.

AI-powered drug discovery company using machine learning to identify and develop novel psychedelic-derived compounds for mental health disorders. Their platform accelerates the identification of serotonergic candidates with therapeutic potential.

Entheon Biomedical is developing DMT-based therapies for addiction and substance use disorders, including alcohol and nicotine dependence. Their clinical programs aim to combine psychedelic-assisted therapy with structured psychological support.

Entorian Technologies develops ultra-miniaturized neural interface electronics and stacked-chip architectures enabling high-density wireless neural recording and stimulation for research and clinical neuroprosthetics applications.

Psychedelic-assisted therapy company operating clinics across North America offering ketamine therapy alongside proprietary digital tools for patient preparation and integration. They also conduct psilocybin research through their drug development subsidiary.

Filament Health is developing natural psychedelic drug candidates extracted from plants, including psilocybin mushrooms and iboga, for addiction and mental health treatment. Their botanical extraction approach differentiates them from synthetic psychedelic competitors.

Leading psychedelic therapy training organization offering continuing education for mental health professionals in ketamine and psychedelic-assisted psychotherapy. Their curriculum is accredited and widely adopted across North America.

GH Research is a clinical-stage biopharmaceutical company developing inhaled 5-MeO-DMT (GH001) as a rapid-acting treatment for treatment-resistant depression. Their proprietary inhalation delivery method is designed to produce predictable, short-duration psychedelic experiences.

GrayMatters Health developed Prism, an EEG-guided closed-loop neurofeedback digital therapeutic for PTSD that trains patients to self-regulate amygdala activity using real-time brain signals.

g.tec medical engineering is an Austrian company producing high-performance biosignal acquisition systems, BCI software, and neurostimulation equipment used in research hospitals and academic neuroscience labs worldwide. Their g.USBamp and g.Nautilus systems are gold standards in BCI and EEG research.

Harmony Biosciences is a commercial-stage pharmaceutical company focused on rare and other neurological diseases, with Wakix (pitolisant) as its lead approved product for excessive daytime sleepiness in narcolepsy. Wakix is the first non-scheduled prescription medicine approved for narcolepsy in the United States.

Canadian psychedelic company focused on the development of standardized natural psilocybin extracts and psychedelic-assisted therapy protocols. Their work bridges traditional plant medicine with modern clinical research frameworks.

Headspace Health merged Headspace and Ginger to create a comprehensive mental health super-app offering meditation, coaching, and on-demand therapy. Their enterprise and health plan products are used by over 100 million people worldwide.

Hi-D Therapeutics is a Singapore-based CNS startup developing deuterium-stabilized analogues of existing neurological drugs to extend half-life and reduce metabolic toxicity in Parkinson's and Huntington's disease.

Ieso Digital Health is a UK-based company delivering internet-enabled cognitive behavioral therapy (iCBT) at scale through trained therapists and an AI-augmented clinical platform. They are a major provider to the NHS Talking Therapies program.

Telehealth platform providing ketamine-assisted therapy for depression, anxiety, and PTSD through a combination of at-home ketamine treatment and virtual psychotherapy. They offer an integrated care model with licensed prescribers and therapists.

Intan Technologies manufactures low-noise, high-channel-count neural recording chips and headstages used by academic and industrial neuroscience researchers globally. Their RHD and RHS series integrated circuits have become a standard in electrophysiology research systems.

InteraXon created the Muse headband, a consumer EEG device that provides real-time brain feedback during meditation and sleep to guide users toward calmer mental states. The Muse S and Muse 2 are among the best-selling consumer neurofeedback devices worldwide.

Intra-Cellular Therapies is a biopharmaceutical company focused on CNS disorders, best known for Caplyta (lumateperone), an FDA-approved treatment for schizophrenia and bipolar depression. Their drug discovery platform targets intracellular signaling pathways in neurons.

Bioventus Neurology offers non-invasive ultrasound-based neuromodulation platforms targeting musculoskeletal pain pathways and peripheral nerve conditions through focused therapeutic ultrasound.

US-based platform enabling licensed therapists to incorporate ketamine-assisted psychotherapy into their practices through a collaborative care model. They provide medical oversight, prescribing infrastructure, and clinical training.

Karuna Therapeutics developed KarXT (xanomeline-trospium), a novel muscarinic receptor-based treatment for schizophrenia that received FDA approval in 2024 under the brand name Cobenfy, representing the first new mechanism of action for schizophrenia in decades. Karuna was acquired by Bristol Myers Squibb in 2024 for approximately $14 billion.

Koa Health is a digital mental health company offering app-based interventions for anxiety, depression, and burnout delivered through employers and health systems. Their platform combines clinical content with AI-driven personalization.

Limbic is a UK-based AI mental health company that builds clinical-grade tools to support therapists and streamline access to psychological therapies. Their AI assessment and support product is integrated into NHS mental health services.

Lumos Labs operates Lumosity, a brain training platform with games designed to challenge memory, attention, flexibility, and problem-solving skills. With over 100 million users, their platform also supports research on cognitive performance.

Formerly MAPS Public Benefit Corporation, Lykos Therapeutics is advancing MDMA-assisted therapy for PTSD through Phase 3 clinical trials and FDA regulatory review. They are a pioneer in the clinical development of psychedelic-assisted psychotherapy.

Lyra Health provides an employer-sponsored mental health platform connecting employees to evidence-based therapists, coaches, and mental health tools through a digital marketplace. Their Lyra Care model blends video therapy, digital programs, and medication management to support the full spectrum of mental health needs.

Magnus Medical developed SAINT (Stanford Accelerated Intelligent Neuromodulation Therapy), a personalized TMS protocol that uses fMRI-guided targeting to deliver rapid antidepressant effects. Their system received FDA Breakthrough Device designation and aims to compress weeks of TMS treatment into days.

Magstim is a leading manufacturer of transcranial magnetic stimulation equipment used in both clinical treatment and neuroscience research, including FDA-cleared TMS systems for major depressive disorder. They supply TMS devices to hospitals, clinics, and research institutions worldwide.

MAPS is a non-profit research and educational organization that has sponsored Phase 3 clinical trials of MDMA-assisted therapy for PTSD through its public benefit corporation subsidiary MAPS PBC. They have been the primary driver of bringing MDMA-assisted psychotherapy toward regulatory approval globally.

mBrainTrain develops portable, wireless EEG amplifiers optimized for mobile brain-body imaging and real-world neuroscience research. Their SMARTING system integrates seamlessly with standard EEG caps and streams data to mobile devices for ambulatory cognitive research.

Medtronic's Neuromodulation division is a global leader in deep brain stimulation (DBS), spinal cord stimulation, and targeted drug delivery for conditions including Parkinson's disease, essential tremor, chronic pain, and epilepsy. Their Percept PC DBS system with BrainSense technology enables real-time neural sensing during therapy delivery.

Mentalab produces the Explore system, a portable and wireless EEG device designed for mobile neuroscience research and BCI development outside the lab. Their open-source compatible hardware enables researchers to run experiments in naturalistic environments.

Meru Health is a digital clinic for depression, anxiety, and burnout that combines therapist-led coaching, biofeedback wearables, and an app-based program. Their 12-week program is clinically validated and covered by major US insurers.

Media, events, and intelligence platform dedicated to psychedelic medicine and business, providing industry news, investment data, and hosting leading global psychedelic conferences. They serve as a key information hub for the emerging psychedelic industry ecosystem.

Mind Alive designs and manufactures audio-visual entrainment and cranio-electro stimulation devices used for relaxation, sleep improvement, and cognitive enhancement. Their DAVID devices are used by practitioners and consumers for non-invasive brainwave entrainment and neurofeedback applications.

Australian non-profit leading efforts to establish regulatory pathways for psilocybin and MDMA-assisted therapies in Australia, successfully achieving landmark TGA rescheduling. They fund clinical research and therapist training programs nationally.

MindAffect develops a rapid, code-modulated visual evoked potential (c-VEP) BCI that enables non-verbal communication for people with ALS and locked-in syndrome. Their open-source platform achieves high information transfer rates using standard EEG headsets without training.

Mental health and wellness company delivering at-home ketamine therapy for depression and anxiety through telemedicine and guided digital experiences. They have treated tens of thousands of patients with a technology-enabled care model.

Digital health platform connecting patients with licensed practitioners for psychedelic integration therapy and mental wellness support. Their app facilitates pre- and post-session care to enhance the durability of psychedelic treatment outcomes.

MindSeaTech develops underwater and maritime human factors monitoring tools using EEG and physiological sensors for defense and research applications. Their wearable neural monitoring systems assess diver and operator cognitive states in extreme environments.

Mindstrong developed passive digital biomarkers derived from smartphone usage patterns to monitor mental health conditions like depression and bipolar disorder. Their platform was designed to support clinical care management for serious mental illness.

Mydecine Innovations is developing psilocybin-based therapies for PTSD and smoking cessation, with a digital therapy platform to support psychedelic treatment. They also have a biosynthesis program to produce novel psilocybin analogues.

myNEURVA provides a clinician-guided neurofeedback platform for cognitive rehabilitation targeting post-concussion syndrome and traumatic brain injury recovery. Their cloud-based system pairs patients with remote neurofeedback therapists.

Endonovo Therapeutics develops wearable pulsed electromagnetic field (PEMF) devices targeting neuroinflammation, delivering non-invasive neuromodulation for traumatic brain injury recovery and chronic pain.

Nalu Medical has created a micro-sized, rechargeable neurostimulation system for chronic pain that is dramatically smaller than conventional implantable pulse generators. Their Nalu Neurostimulation System enables flexible programming and remote care capabilities for patients with back and limb pain.

Natus Medical is a leading provider of neurology and newborn care medical devices, offering products for EEG, EMG, evoked potentials, and newborn hearing screening. Their Nicolet and Excel-Tech EEG systems are used in hospitals and neurology clinics across more than 100 countries.

Neeuro is a Singapore-based neurotechnology company that develops EEG-based cognitive training and monitoring platforms for healthcare and education. Their SenzeBand EEG headset and Memorie brain training app target cognitive health in aging populations and children with learning challenges.

Neuromod Devices is an Irish MedTech company that developed Lenire, a CE-marked bimodal neuromodulation device combining tongue and sound stimulation to treat chronic tinnitus.

Neumora Therapeutics is a clinical-stage biopharmaceutical company applying precision medicine to brain diseases, with a pipeline targeting depression, schizophrenia, and other psychiatric disorders through novel receptor-targeted mechanisms. Their lead asset navacaprant is a kappa opioid receptor antagonist in Phase 3 trials for major depressive disorder.

Neurable integrates passive BCI technology into consumer headphones to measure focus and cognitive state throughout the workday. Their MW75 Neuro headphones use dry EEG sensors to deliver personalized productivity insights without any additional hardware.

Neuracle Neuroscience develops clinical-grade wireless EEG monitoring systems for long-term ambulatory brain monitoring in epilepsy diagnosis, ICU care, and neurological disease management. Their NeuroCap disposable pre-gelled EEG cap dramatically reduces setup time and infection risk compared to traditional EEG electrode placement in clinical settings.

Neural Analytics developed the Lucid system, an AI-powered transcranial Doppler ultrasound device for automated brain health assessment at the bedside. Their technology enables non-invasive monitoring of cerebral blood flow dynamics to detect conditions like vasospasm and elevated intracranial pressure.

The BrainGate Consortium is a multi-institutional research collaboration between Brown University, Stanford, Case Western, and Massachusetts General Hospital pioneering intracortical BCI technology for restoring communication and motor function in paralysis. Their Utah array-based implants have enabled landmark demonstrations of cursor control, robotic arm use, and speech decoding in clinical trial participants.

Neuracle Neuroscience is a Chinese neurotechnology company developing wireless EEG systems and BCI platforms for clinical and consumer applications. Their NeuSen W series wireless EEG headsets are used in hospitals and research institutions across Asia.

Neuralign has developed a digital platform that uses standardized neuropsychological assessments and EEG biomarkers to identify and treat reading and learning disabilities in children. Their Lokomat-compatible neurofeedback and cognitive training tools are deployed in schools and clinics.

Synchron's Australian operations and clinical trial hub developed the Stentrode, a minimally invasive endovascular BCI implanted via a blood vessel without open brain surgery. Their device has enabled ALS patients to control computers and smartphones through motor imagery.

Neuraltus Pharmaceuticals is developing NP001, a novel immunomodulatory therapy targeting neuroinflammation in ALS patients by reprogramming inflammatory macrophages and microglia.

NeuraVi is an Australian neuromodulation startup developing closed-loop vagus nerve stimulation devices targeting treatment-resistant depression and inflammatory disorders.

Neurescence develops miniaturized multiphoton microscopy systems enabling researchers to image neural activity in freely behaving animals with unprecedented resolution.

Neuroadaptive Technologies develops passive BCI systems that use real-time EEG to infer cognitive states and adapt machine behavior accordingly without explicit user input. Their research focuses on workload monitoring and human-automation teaming for aerospace and defense applications.

Neurobiological Technologies is a CNS pharmaceutical company that developed NeuroBiological Technologies (NBT) platform for neuroprotective peptide therapies targeting acute neurological injury and neurodegeneration.

Neurogene is a gene therapy company developing NGN-101, an AAV-based treatment for CLN5 Batten disease, using a proprietary EXACT technology platform to regulate transgene expression in the CNS.

Neuroelectrics designs wireless, high-density EEG and transcranial electrical stimulation systems for research and clinical neuromodulation. Their Starstim platform enables simultaneous multi-channel tCS and EEG recording in a single wearable headset.

NeuroEne Therapeutics is an Israeli startup developing endocannabinoid-based CNS modulators for treatment-resistant epilepsy and neuropathic pain, leveraging proprietary lipid nanoparticle delivery technology.

Neurolutions developed the IpsiHand Upper Extremity Rehabilitation System, a BCI-powered exoskeleton that helps stroke survivors regain hand and arm function. The device received FDA Breakthrough Device designation and is used in clinical stroke rehabilitation settings.

Neuromed is an Italian medical device company specializing in implantable spinal cord stimulation and deep brain stimulation systems for chronic pain and movement disorders. Their Ares DBS and SCS platforms are distributed across European clinical centers.

Neurona Therapeutics is developing NRTX-1001, a one-time cell therapy using human interneurons derived from stem cells to treat drug-resistant focal epilepsy through targeted circuit modulation.

NeuroPhos Therapeutics is a Swedish clinical-stage company developing phospholipid-based nanoparticle drug delivery systems to enhance CNS bioavailability of neurological therapeutics.

Specialty pharmaceutical company developing intranasal delivery formulations of psychedelic compounds including psilocybin and ketamine for rapid onset psychiatric treatment. Their proprietary nasal delivery technology improves bioavailability and dose precision.

Neuronetics is a publicly traded medical device company that markets the NeuroStar Advanced Therapy System, an FDA-cleared TMS platform for major depressive disorder and obsessive-compulsive disorder. Their system has treated over 100,000 patients across thousands of clinical practices in the US.

NeurOptimal, developed by Zengar Institute, offers a dynamical neurofeedback system that trains the brain using real-time EEG feedback without targeting specific brainwave states. Their system is used by clinicians and consumers worldwide for stress, sleep, and performance optimization.

Quanta System develops laser-based neurosurgical and neuromodulation platforms used in minimally invasive brain and spine procedures worldwide.

Cala Health develops wrist-worn peripheral nerve stimulation therapy (Cala Trio) for essential tremor, delivering individualized transcutaneous stimulation calibrated to each patient's tremor frequency.

Neuros Medical is developing the HFAC (High-Frequency Alternating Current) Nerve Block technology to treat chronic post-amputation pain through a minimally invasive implantable device that blocks pain signals at the peripheral nerve. Their Altius system has received FDA Breakthrough Device Designation and targets one of the most undertreated pain conditions in veterans and amputees.

Nevro Corp develops high-frequency spinal cord stimulation therapy for chronic pain conditions including painful diabetic neuropathy.

Neurotrack has developed an eye-tracking cognitive assessment tool that detects early signs of Alzheimer's disease and cognitive decline using a standard webcam. Their digital platform supports both clinical research and consumer brain health monitoring.

Nevro is a publicly traded medical device company offering the HFX spinal cord stimulation platform delivering 10 kHz high-frequency therapy for chronic back and leg pain without paresthesia.

Nevro is a publicly traded medical device company specializing in spinal cord stimulation therapy for chronic pain, best known for its HF10 high-frequency SCS platform that operates at 10 kHz to reduce paresthesia. Their devices are FDA-approved for treating intractable back and leg pain.

Nexstim is a Finnish medical technology company specializing in navigated brain stimulation, offering the NBS System for neurosurgical planning and the NBT System for treating major depressive disorder with TMS. Their proprietary eXimia technology provides precise, image-guided transcranial magnetic stimulation.

Nihon Kohden is a major Japanese medical electronics company producing a comprehensive range of EEG, EMG, and polysomnography systems used globally in clinical neurology and sleep medicine. Their monitoring platforms are known for precision signal quality and are trusted in ICU and epilepsy monitoring units worldwide.

Impact investment fund dedicated to supporting psychedelic science, therapy access, and policy reform through philanthropic and mission-aligned capital. They fund research institutions, advocacy organizations, and clinical programs globally.

Novamind operates ketamine-assisted therapy clinics and conducts psychedelic clinical research across the United States and Canada. Their network of Cedar Psychiatry and Novamind clinics integrates evidence-based psychedelic treatments with psychiatric care.

Psychedelic-assisted therapy training and retreat organization providing evidence-based programs integrating mystical experience frameworks with clinical practice. They focus on therapist education and patient preparation protocols.

Digital mental health company offering at-home ketamine therapy combined with proprietary digital integration programs and health coaching. Their platform uses data science to personalize treatment and track outcomes longitudinally.

Numinus Wellness is a Canadian publicly listed mental health company operating clinics that offer ketamine-assisted therapy and psychedelic-assisted psychotherapy, while also running a Health Canada-licensed facility for psychedelic research and compound production. They bridge clinical care and drug development in the psychedelic medicine space.

Nurokor is an Australian medtech company developing bioelectronic neuromodulation devices that use targeted electrical stimulation to improve athletic performance and rehabilitation outcomes. Their wearable technology is used by elite sports teams globally.

Nuvectra was a publicly traded neurostimulation company that developed the Algovita spinal cord stimulation system for chronic pain management. The company also had DBS and sacral neuromodulation platforms under development before ceasing operations.

Orexo develops sublingual and digital-therapeutic combination products targeting opioid use disorder and central nervous system conditions.

Israeli neurotechnology company developing non-invasive closed-loop brain stimulation devices that adapt in real-time to neural biomarkers for treating psychiatric and neurological disorders. Their platform integrates EEG monitoring with transcranial stimulation to personalize therapy.

Open Ephys is a nonprofit organization that develops open-source hardware and software for extracellular electrophysiology research. Their Open Ephys GUI and acquisition board are widely adopted in academic neuroscience labs for high-channel neural recording.

OpenBCI makes open-source brain-computer interface hardware and software, including the Cyton, Ganglion, and Ultracortex headsets, designed to democratize access to EEG and biopotential sensing for researchers, developers, and makers. Their open ecosystem has fostered a broad community of BCI innovation worldwide.

Osmind provides an EHR and practice management platform specifically designed for psychiatric providers offering innovative treatments like ketamine, TMS, and esketamine (Spravato). Their software streamlines patient intake, outcome tracking, and billing for cutting-edge mental health clinics.

Perception Neuroscience is developing arketamine (R-ketamine) as a rapid-acting antidepressant with a potentially more favorable side-effect profile than esketamine. Their program targets treatment-resistant depression and suicidal ideation.

Supernus Pharmaceuticals is a CNS-focused specialty pharmaceutical company commercializing Oxtellar XR and Trokendi XR for epilepsy, and Qelbree for ADHD, with an active neuropsychiatry pipeline.

Persyst develops AI-powered EEG analysis software that automates spike detection, seizure identification, and quantitative EEG analysis to assist neurologists in reading complex EEG recordings more efficiently. Their Persyst 14 platform integrates with major EEG hardware vendors and is used in clinical and research settings.

Philips Neuro, a division of Royal Philips, offers a comprehensive portfolio of EEG systems, long-term monitoring solutions, and diagnostic neurology software used in hospital neurology departments and ICUs worldwide. Their Alice and Natus-integrated platforms support epilepsy monitoring, sleep studies, and intraoperative neuromonitoring.

Photopharmics develops the Celeste light therapy device, a precisely calibrated intrinsically photosensitive retinal ganglion cell (ipRGC) stimulator designed to treat Parkinson's disease non-motor symptoms.

San Francisco-based clinical center specializing in ketamine-assisted psychotherapy and training mental health professionals in psychedelic-assisted treatment modalities. They integrate depth psychology with emerging psychedelic medicine practices.

Posit Science develops BrainHQ, a suite of evidence-based brain training exercises targeting processing speed, memory, and attention validated in over 100 peer-reviewed studies. Their platform is used by healthcare systems, employers, and consumers to improve cognitive function.

Prefrontal Health delivers AI-driven digital therapeutics targeting executive function and cognitive resilience for patients with ADHD and traumatic brain injury.

Biotechnology company developing next-generation psychedelic-derived therapeutics targeting neurological and psychiatric disorders. They focus on novel analogs of psilocybin and DMT with improved pharmacological profiles.

Leading psychedelic industry research and intelligence platform tracking clinical trials, regulatory developments, and company news across the global psychedelic medicine space. They provide data-driven insights for investors and researchers.

Digital mental health company building AI-powered tools to personalize and monitor psychedelic-assisted therapy sessions and patient outcomes. Their platform supports therapists with real-time biometric and psychological state tracking.

Neurotechnology company developing EEG-based biomarkers and digital cognitive assessments to predict and monitor response to psychedelic-assisted therapies. Their platform provides objective neurological metrics to support clinical decision-making.

Psych360 is a mental health technology company focused on expanding access to ketamine-assisted therapy and psychedelic-informed psychiatric care through a network of outpatient clinics and digital health tools. They aim to bridge the gap between emerging psychedelic science and accessible, evidence-based outpatient psychiatric treatment.

Quartet Health is a tech-enabled mental health platform that connects patients with the right behavioral health care through health system partnerships. Their technology identifies patients in need and coordinates care between physical and mental health providers.

Reata Pharmaceuticals developed omaveloxolone (Skyclarys), the first FDA-approved treatment for Friedreich's ataxia, acting as an Nrf2 activator to reduce oxidative stress in neuronal mitochondria.

Reunion Neuroscience is developing RE104, a novel psychedelic compound with a shorter duration of action than psilocybin, targeting postpartum depression and major depressive disorder. Their approach aims to improve practicality of psychedelic-assisted therapy.

Canadian specialty pharmaceutical company advancing psilocybin and cannabidiol-based therapeutics for rare diseases and mental health conditions. Their lead program targets treatment-resistant PTSD with psilocybin-assisted therapy.

Ripple Neuro develops high-channel-count neural interface systems for intraoperative and chronic recording applications. Their Grapevine neural interface processor is widely used in clinical and research BCIs worldwide.

Rune Labs builds software infrastructure for neural data, enabling clinicians and researchers to leverage data from implanted neurostimulators like Medtronic's Percept. Their StrivePD platform integrates neural biomarkers with wearable data to optimize Parkinson's treatment.

Sage Therapeutics is a biopharmaceutical company pioneering GABA and NMDA receptor-targeted medicines for brain health disorders, with Zurzuvae (zuranolone) being the first once-daily oral pill FDA-approved for postpartum depression. They continue to advance a pipeline targeting major depressive disorder, epilepsy, and essential tremor.

SC Neuro is a Canadian neurostimulation company developing non-invasive spinal cord stimulation devices for restoring upper and lower limb function in patients with spinal cord injury.

Seelos Biosciences is a clinical-stage company developing intranasal racemic ketamine (SLS-002) for acute suicidal ideation and behavior in major depressive disorder. They have a broader pipeline targeting CNS and rare disease indications.

Neuros Medical develops the HALO system, a high-frequency nerve block neurostimulator designed to treat post-amputation phantom limb pain by non-destructively silencing peripheral nerve activity.

Psychedelic wellness company operating legal psilocybin mushroom retreats in Jamaica and developing metered-dose functional mushroom products. They focus on making psychedelic experiences accessible under legal jurisdictions.

SilverCloud Health provides digital mental health and wellbeing programs based on CBT, delivered to patients through health systems and employers. Acquired by Amwell, their platform serves millions of users across Ireland, the UK, and North America.

Small Pharma is a clinical-stage psychedelic medicine company developing short-duration DMT-assisted therapy for major depressive disorder. Their lead program SPL026 has completed Phase IIa trials in the UK.

Spinal Modulation pioneered dorsal root ganglion (DRG) stimulation therapy for localized chronic pain, developing the Axium Neurostimulator System acquired by St. Jude Medical.

Spring Health is an employer-focused mental health benefits platform that uses machine learning to personalize mental health care, matching employees to the right level of care including therapy, coaching, and medication management. They have become one of the most well-funded mental health startups in the US.

Stimwave develops wireless, minimally invasive neurostimulation devices for chronic pain management, featuring the world's smallest spinal cord stimulator powered by external radio frequency energy.

Supernus Pharmaceuticals is a specialty CNS biopharmaceutical company with a portfolio of approved products for epilepsy, ADHD, and Parkinson's disease, including Oxtellar XR, Trokendi XR, Qelbree, and Gocovri. They focus on developing differentiated medicines for underserved neurological conditions.

Synapse Biomedical developed the NeuRx Diaphragm Pacing System, an FDA-approved implantable neurostimulator that electrically conditions the diaphragm to restore breathing in ALS and spinal cord injury patients.

Netherlands-based legal psilocybin retreat and training organization offering psychedelic-assisted therapy programs for professionals and individuals. They also train facilitators through accredited certification programs.

Drug discovery company developing entactogen-based medicines derived from MDMA analogs for psychiatric conditions including PTSD and social anxiety. Their pipeline focuses on compounds with refined safety and efficacy profiles.

Canadian non-profit advocacy organization that secured the first legal psilocybin therapy exemptions in Canada and supports patient access to psilocybin for end-of-life distress. They also provide therapist training and regulatory guidance.

Thought Technology is a Canadian company manufacturing multi-modal biofeedback and neurofeedback instruments used in clinical, research, and performance settings. Their ProComp and FlexComp systems measure EEG, EMG, HRV, and other physiological signals for therapeutic training.

TMS Health Solutions operates a network of outpatient TMS therapy clinics across the United States, providing transcranial magnetic stimulation treatment for major depressive disorder and OCD.

Translatum Medicus is a Greek biopharmaceutical startup developing novel adenosine receptor modulators and neuroinflammation inhibitors for Parkinson's disease and Huntington's disease.

Tryp Therapeutics is developing psilocybin-based therapies for eating disorders, fibromyalgia-associated depression, and other conditions with high unmet need. They focus on specific patient populations where psychedelic-assisted therapy may offer significant benefit.

Two Chairs is a mental health clinic combining therapist matching technology with in-person and virtual therapy services across the United States. Their data-driven matching platform aims to improve therapy outcomes and reduce dropout rates.

Usona Institute is a nonprofit medical research organization conducting Phase 3 clinical trials of psilocybin for major depressive disorder. As a mission-driven organization, they aim to develop psilocybin as an accessible, non-proprietary medicine.

Neurexo Biosciences is a German spin-out developing exosome-based RNA therapeutics for acute CNS injuries including stroke and traumatic brain injury, leveraging engineered extracellular vesicles for BBB penetration.

UK-based company developing AI-driven therapeutic music tools designed to support psychedelic-assisted therapy sessions. Their platform personalizes sound environments to optimize patient emotional states during treatment.

Wesana Health is a psychedelic medicine company focused on developing psilocybin-based treatments for traumatic brain injury and associated mental health conditions. They are building a pipeline targeting neurological damage and PTSD.

Woebot Health develops an AI-powered mental health chatbot that delivers cognitive behavioral therapy (CBT) techniques through conversational interfaces. Their flagship product helps users manage anxiety, depression, and stress in real time.

Wysa is an AI-powered emotional wellbeing app that uses evidence-based CBT, DBT, and mindfulness techniques delivered via a conversational chatbot. It is used by millions globally and has partnerships with healthcare systems in the UK and India.

Zai Lab is a China-based biopharmaceutical company with a growing CNS pipeline including partnered assets for major depressive disorder, schizophrenia, and Parkinson's disease targeting Asian patient populations.